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ABSTRACT

Heart failure (HF) has become a major health problem with its high prevalence, poor
clinical outcomes, and large health-care costs. Compared with medical intervention, the
prevention of HF through lifestyle approaches is free of side effect. Therefore, the prevention
of HF through lifestyle approaches is of special interest. In this project, we aim to investigate
1) the association of different levels of occupational, commuting and leisure-time physical
activity with HF risk; 2) the association of coffee consumption with HF risk; 3) the role of
lifestyle factors in explaining the risk of HF; and 4) the association between antihypertensive
drug treatment and HF risk with the association between engaging in a healthy lifestyle and
HF risk.
We conducted prospective studies among Finnish men and women who were 25 to 74
years of age and free of HF at baseline. Cox proportional hazards regression models were
used to estimate the associations of interest. Partial population attributable risk was
calculated to estimate the proportion of new HF cases occurring in this population that
hypothetically could have been prevented if all subjects had certain health lifestyle factors.
Our study results showed that 1) moderate and high levels of occupational or
leisure-time physical activity are associated with a reduced risk of HF in both sexes; A
simultaneous engagement in two or three types of physical activity showed a slightly
stronger protective effect than participation in only one type of physical activity; 2) coffee
consumption does not increase the risk of HF in Finnish men and women; In women, we
observed an inverse association between low-to-moderate coffee consumption and the risk of
HF; 3) maintaining a body mass index ≤25, consuming vegetable ≥3 times a week,
viii

abstaining from smoking and engaging in moderate or high level of physical activity were
individually and jointly associated with a decreased risk of HF among both men and women;
The relationship between the number of healthy lifestyle factors one engaged in and HF risk
was dose-response; and 4) HF risk was lower in hypertensive patients who engaged in a
healthy lifestyle but higher in hypertensive people using antihypertensive drug treatment.

ix

CHAPTER 1. OVERVIEW
1.1 Introduction
Heart Failure (HF) has emerged as a major and growing health problem both in the
developed and developing regions of the world.(Schocken et al., 2008a) Although use of
medication has reduced re-hospitalization rates and mortality from HF,(Lee et al., 2004) it
remains the leading cause of hospitalization for older people in the United States.(Kozak et
al., 2006) Mortality among HF patients remains substantial. About one quarter of patients
died within one year of diagnosis and half died within five years of diagnosis.(Levy et al.,
2002; Roger et al., 2004) Therefore, the prevention of HF through lifestyle approaches is of
special interest. The association of lifestyle factors with HF risk will be evaluated in the
studies described in this application using the FINRISK Study, conducted in Finland.
The FINRISK Study is one of the largest prospective epidemiological studies of chronic
disease risk factors in the world. The total sample consists of 62,013 randomly selected
individuals (30,031 men and 31,982 women) aged 25-74 years. Baseline data collections
include medical history, socio-economic factors, lifestyle factors, and the direct
measurements of height, weight, blood pressure, and serum total cholesterol. The follow-up
is virtually complete through the nationwide register linkage. During a mean follow-up of
18.4 years, 1992 men and 1771 women developed incident HF. Thus, this is one of the
largest prospective studies of HF in the world. The existing data and data which will be
generated during further follow-up of this cohort provide a unique opportunity to identify
potential preventive strategies for HF.
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Specifically, we provide detailed evaluations of the following research questions in this
dissertation:

Research Questions
1. Does physical activity during occupation, commuting, and/or leisure time decrease
HF risk?
2. Does coffee consumption influence the risk of HF?
3. What are the joint effects of lifestyle factors (physical activity, alcohol consumption,
coffee consumption, smoking, and obesity) on the risk of HF?
4. Whether there are differences in HF risk among hypertensive men and women using
antihypertensive drug treatment at baseline versus those engaging in a healthy
lifestyle at baseline?

Hypotheses
1. Physical activity during occupation, commuting, and/or leisure time decrease HF
risk.
2. Coffee consumption influences HF risk.
3. Lifestyle factors (physical activity, alcohol consumption, coffee consumption,
smoking, and obesity) influences HF risk.
4. Differences exist in HF risk among hypertensive men and women using
antihypertensive drug treatment at baseline versus those engaging in a healthy
lifestyle at baseline

2

Justification
According to the World Health Organization (WHO), the knowledge about the
epidemiology, risk factors, prognosis, treatment, and prevention of coronary heart disease
(CHD) and stroke has been investigated more systematically than that of HF because only a
few population-based epidemiologic studies are available for HF.(World Health
Organization) Data from a few population-based epidemiologic studies in the US and Europe
have provided evidence that lifestyle factors play an important role in the etiology of HF.(He
et al., 2001; Kannel et al., 1999; Schocken et al., 2008a) Thus, the prevention of HF through
lifestyle approaches is possible. In order to determine interventions that would prevent or
delay the onset of HF, identification of modifiable risk factors for HF is indispensable
because these risk factors could then be used as targets for intervention. Therefore,
independent confirmation and further exploration of lifestyle factors with the risk of HF in
well-designed large prospective studies will provide crucial information for us to gain a
better understanding of the complex lifestyle-HF relationships.
The present study, which is part of the FINRISK study, utilized a prospective cohort
design. The subjects involved in this study were general population of Finland. The study
sample was nationally representative. The present study would provide important information
for understanding the causes and prevention strategies of HF.

Limitations
1. Study cohorts represented random samples of Finnish men and women. However,
results of the present study may not be able to generalize to other populations.
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2. Even though we gathered data on several potential confounders such as age,
education, blood pressure, total cholesterol etc., residual confounding due to
measurement error in the assessment of confounding factors, or some unmeasured
dietary factors were not determined thus, cannot be excluded.
3. All exposure and covariate information was measured at baseline surveys prior to HF
diagnoses. We have no data on possible changes in these factors during the follow-up.
The misclassification of the levels of these factors during the follow-up is most
probably not systematically related to the outcome, but may weaken the observed
association.

1.2 Review of literature

Epidemiology of HF
HF has emerged as a worldwide epidemic and is one of the leading causes of morbidity
and mortality for old people in the US and other Western countries.(He et al., 2001;
Nieminen and Harjola, 2005) According to the estimation of American Heart Association
(AHA), 550,000 new cases occur each year, and more than 5 million Americans have
HF.(Schocken et al., 2008a) According to the estimation of the European Society of
Cardiology (ESC), 10 million people have HF in the Europe, and HF patients accounts for
0.4% to 2% of the general European population.(Nieminen and Harjola, 2005) In addition,
HF has put a heavy economic burden on the society. An estimated of > $33 billion was spent
on HF in 2007 according to AHA.(Schocken et al., 2008a)
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Overweight/obesity, physical activity and HF1
The epidemic of unhealthy lifestyle habits including, overweight/obesity and sedentary
lifestyle has serious public health and economic consequences. Obesity, which may be
caused by unhealthy diet and/or physical inactivity, has long been regarded as a major public
health problem in the US(Allison et al., 1999). The data from a community-based study
conducted among subjects aged 65 years and over living in New Haven has shown that
obesity, as assessed by body mass index (BMI: calculated as weight [kilogram] divided by
height squared [square meter]) ≥28, is a predictor for HF risk.(Chen et al., 1999) This finding
has been confirmed by many other studies.(Bahrami et al., 2008; He et al., 2001; Hu et al.;
Ingelsson et al., 2005b; Ingelsson et al., 2005c; Kenchaiah et al., 2002; Kenchaiah et al.,
2009; Levitan et al., 2009a; Loehr et al., 2009; Nicklas et al., 2006) It was not until recent
years that scientists began to include the indexes of abdominal obesity: waist circumference
(WC), waist-to-hip ratio (WHR: WC [centimeter] divided by hip circumference [centimeter]),
waist-height ratio (WHtR: WC [centimeter] divided by height [centimeter]) and waist-to-thigh
ratio (WTR: WC [centimeter] divided by thigh circumference [centimeter]) into their
studies.(Bahrami et al., 2008; Hu et al., 2010b; Ingelsson et al., 2005c; Levitan et al., 2009a;
Loehr et al., 2009; Nicklas et al., 2006) These studies reveal that these indexes are also predictors
of HF risk. Prospective epidemiological studies that investigated the association between

obesity and HF were summarized in table 1. The results from these prospective studies
consistently indicate that both general obesity and abdominal obesity increase the risk of HF.
The increase in computerization and mechanization during the last decades has resulted in
1

This section originally appeared as Yujie Wang and Gang Hu. The individual and joint associations of obesity and
physical activity on the risk of heart failure. Congestive Heart Failure, 16(6), 292-299, 2010. Reprinted by permission of
John Wiley and Sons. http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7133.2010.00189.x/abstract
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ever-increasing numbers of people being sedentary for most of their time. In the US, more than
one half of the adults do not engage in physical activity at the level currently recommended for
health promotion.(Pate et al., 1995; Thompson et al., 2003) In response to this severe situation,
three studies have looked into the association between regular physical activity and HF risk.(He
et al., 2001; Hu et al., 2010b; Kenchaiah et al., 2009) Prospective epidemiological studies that

investigated the association between physical activity and HF were summarized in table 2.
The results from these prospective studies consistently indicate that regular physical activity
reduces the risk of HF. However, most previous studies focused on leisure time physical

activity alone and the evidence on other types of physical activity, such as occupational or
commuting physical activity, is sparse. It is unclear whether different forms of physical
activity are independently related to a reduced risk of incident HF, and the joint effects of
different types of physical activity would reduce the risk of HF further.
Coffee consumption and HF
Coffee is one of the most widely consumed beverages in the world.(Popkin et al., 2006)
It has been suggested that coffee consumption may be associated with the risk of coronary
heart disease (CHD),(Wu et al., 2009) hypertension,(Corti et al., 2002; Jee et al., 1999;
Lovallo et al., 2004; Noordzij et al., 2005; Winkelmayer et al., 2005) and lower risk of type
2 diabetes,(Tuomilehto et al., 2004; van Dam and Hu, 2005)all of which are known risk
factors of HF.(Ho et al., 1993; Kannel et al., 1974; Levy et al., 1996) Two prospective
studies have previously investigated the association between coffee consumption and HF risk
among Swedish men.(Ahmed et al., 2009; Wilhelmsen et al., 2001) The first prospective
study on the relation between coffee consumption and the risk of HF was conducted among
6

Table 1. Selected findings on the association between obesity and the risk of heart failure
Author, year

No. of heart failure cases

Age range

/No. of participants*

(years)

Chen et al,

173 (85M/88F)

≥65

1999(Chen et

/1749 (718M/1031F)

Follow-up

Major findings, BMI (kg/m2)

Adjustment factors

Hazard ratios (95% CI)

General obesity
10-year

BMI <24, HR 1.00 (reference)

Sex, age, DM, pulse pressure, MI during

BMI 24-27.9, HR 1.1 (0.7-1.7)

follow-up, and

type of housing

BMI ≥28, HR 1.8 (1.1-2.7)

al., 1999)
He et al，

1382 (741M/641F）

2001(He et al.,

/13643(5545M/8098F)

25-74

19-year

2001)

Male

Age, race, education level, smoking, regular

BMI <27.8, HR 1.00 (reference)

alcohol consumption, SBP, low physical

BMI ≥27.8, HR 1.23 (1.00-1.52)

activity, hypertension, history of DM, history

Female

of valvular

heart disease, and history of CHD

BMI <27.3, HR 1.00 (reference)
BMI ≥27.3, HR 1.34 (1.10-1.64)
Kenchaiah et

496 (238M/258F)

al,

/5881(2704M/3177F)

2002(Kenchaia

55 (mean)

14-year

each 1-unit increase in BMI

Alcohol consumption, serum total cholesterol,

Male, HR 1.05 (1.02-1.09)

presence or absence of current smoking, valve

Female, HR 1.07 (1.04-1.10)

disease, hypertension, DM, ECG-LVH, and MI

h et al., 2002)
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Table 1 continued
Ingelsson et al,

104M/1187M

≥70

2005(Ingelsson

8.9-year

each 1-SD increase in BMI

DM, prior MI, hypertension, ECG-LVH,

(median)

HR 1.35 (1.11-1.65)

smoking, and serum cholesterol

28.8-year

each 1-SD increase in BMI

Prior acute MI, hypertension, DM, ECG-LVH,

(median)

HR 1.47 (1.31-1.65)

smoking, and serum cholesterol

et al., 2005c)
Ingelsson et al,

259M/2321M

≥50

2005(Ingelsson
et al., 2005b)
Nicklas et al,

166 (73M/93F)/ 2435

6.1-year

each 1-SD increase in BMI

Age, sex, race, site, education, smoking,

2006(Nicklas

(1081M/1354F)

(median)

HR 1.25 (1.02-1.53)

chronic obstructive pulmonary disease,

et al., 2006)

inflammation, incident MI, homeostasis model
assessment of insulin sensitivity index, DM,
and hypertension

Bahrami et al,

79/6814 (3204M/3610F)

45-84

2008(Bahrami

4-year

BMI <30, HR 1.00 (reference)

Age, gender, hypertension, DM, LVH, Serum

(median)

BMI ≥30, HR 1.83 (1.14-2.92)

total cholesterol, and current smoking,

16-year

each 1-SD increase in BMI

Age, alcohol use, educational level, smoking

(median)

Male, HR 1.47 (1.39-1.57)

status, and center

et al., 2008)
Loehr et al,

1528(825M/703F)

2009(Loehr et

/14641(6632M/8009F)

al., 2009)

45-65

Female, HR 1.49 (1.39-1.59)
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Table 1 continued
Kenchaiah et

1109M/21094M

40-84

20.5-year

BMI <25, HR 1.00 (reference)

Age, smoking, alcohol consumption, parental

al,

BMI 25-29.9, HR 1.49 (1.32-1.69)

history of MI, random assignment to aspirin or

2009(Kenchaia

BMI ≥30, HR 2.80 (2.24-3.50)

β-carotene, vigorous physical activity, history

h et al., 2009)

of hypertension, DM, and
hypercholesterolemia

Levitan et al,

1100 (718M/382F)

45-79M

7-year

An interquartile range increase in BMI

Age, education, smoking, alcohol

2009(Levitan

/80360(43487M /36873F)

/48-83F

(median)

Male, HR 1.27 (1.19-1.36)

consumption, total physical activity,

Female, HR 1.12 (1.00-1.24)

postmenopausal hormone therapy, living alone,

et al., 2009a)

marital status, and family history of MI,
hypertension, high cholesterol, and DM
Hu et al,

3614 (1921M/1693F)/

2010(Hu et al.,

59178 (28842M/30336F)

2010b)

25-74

18.4-year

Male

Age, study year, education, smoking, alcohol

BMI <25, HR 1.00 (reference)

consumption, history of MI, valvular heart

BMI 25-29.9, HR 1.25 (1.12-1.39)

disease, DM, SBP, total cholesterol, and

BMI ≥30, HR 1.99 (1.74-2.27)

physical activity

Female
BMI <25, HR 1.00 (reference)
BMI 25-29.9, HR 1.33 (1.16-1.51)
BMI ≥30, HR 2.06 (1.80-2.37)
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Table 1 continued
Abdominal obesity
Ingelsson et al,

104M/1187M

≥70

2005(Ingelsson

8.9-year

each 1-SD increase in WC

DM, prior MI, hypertension, smoking, ECG

(median)

HR 1.36 (1.10-1.69)

LVH, and serum total cholesterol

et al., 2005c)
Nicklas et al,

166 (73M/93F)/ 2435

6.1-year

each 1-SD increase in WC

Age, sex, race, site, education, smoking,

2006(Nicklas

(1081M/1354F)

(median)

HR 1.32 (1.12-1.55)

chronic obstructive pulmonary disease,

each 1-SD increase in WTR

inflammation, incident MI, homeostasis model

HR 1.15 (0.96-1.36)

assessment of insulin sensitivity index, DM,

et al., 2006)

and hypertension
Bahrami et al,

79/6814 (3204M/3610F)

45-84

2008(Bahrami

4-year

WC >102 cm in men, WC >88 cm in women

Age, gender, hypertension, DM, LVH, Serum

(median)

HR 2.06 (1.25-3.41)

cholesterol, and current smoking,

16-year

each 1-SD increase in WC

Age, alcohol use, educational level, smoking

(median)

Male, HR 1.52 (1.43-1.62)

status, and center

et al., 2008)
Loehr et al,

1528(825M/703F)

2009(Loehr et

/14641(6632M/8009F)

al., 2009)

45-65

Female, HR 1.54 (1.44-1.66)
each 1-SD increase in WHR
Male, HR 1.50 (1.41-1.60)
Female, HR 1.59 (1.46-1.72)
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Table 1 continued
Levitan et al,

1100(718M/382F)

45-79M

7-year

An interquartile range increase in WC

Age, education, smoking, alcohol

2009(Levitan

/80360(43487M /36873F)

/48-83F

(median)

Male, HR 1.31 (1.21-1.42)

consumption, total physical activity,

Female, HR 1.20 (1.05-1.36)

postmenopausal hormone therapy, living alone,

An interquartile range increase in WHR

marital status, and family history of MI,

Male, HR 1.08 (1.00-1.17)

hypertension, high cholesterol, and DM

et al., 2009a)

Female, HR 1.02 (0.93-1.12)
An interquartile range increase in WHtR
Male, HR 1.28 (1.18-1.39)
Female, HR 1.14 (1.00-1.31)
Hu et al,

3614 (1921M/1693F)/

2010(Hu et al.,

59178(28842M/30336F)

2010b)

25-74

18.4-year

each 1-cm increase in WC

Age, study year, education, smoking, alcohol

Male, HR 1.03 (1.02-1.04)

consumption, history of MI, valvular heart

Female, HR 1.04 (1.03-1.05)

disease, DM, SBP, total cholesterol, physical

each 0.1-unit increase in WHR

activity

Male, HR 1.48 (1.25-1.75)
Female, HR 1.64 (1.31-2.04)

*The number of subjects are those were finally included in the analyses.
Abbreviations: BMI=body mass index, CHD=coronary heart disease, DM=diabetes mellitus, ECG=Electrocardiograph, MI=myocardial
infarction, SBP=systolic blood pressure, WC= waist circumference, WHR=waist-to-hip ratio, LVH=left ventricular hypertrophy, HR=hazard
ratio, WTR=waist-to-thigh ratio.

11

Table 2. Selected findings on the association between physical activity and the risk of heart failure
Author, year

No. of heart failure

Age

cases /No. of

range

participants*

(years)

He et al,

1382 (741M/641F）

25-74

2001(He et al.,

/13643(5545M/8098F)

Follow-up Major findings

Adjustment factors

Hazard ratios (95% CI)

19-year

Regular exercise, HR 1.00

Age, race, education level, smoking,

(reference)

regular alcohol consumption, SBP,

Low exercise,

overweight, hypertension, history of

Male, HR 1.14 (0.94-1.38)

DM, history of valvular

Female, HR 1.31 (1.11-1.54)

and history of CHD

Vigorous physical activity

Age, cigarette smoking, alcohol

2009(Kenchaiah

Low, HR 1.00 (reference)

consumption, parental history of MI,

et al., 2009)

Active ≥1-3 times/mo, HR 0.82

random assignment to aspirin or

(0.70-0.96)

β-carotene, BMI, the presence or

2001)

Kenchaiah et al,

1109M/21094M

40-84

20.5-year

heart disease,

absence of history of hypertension, DM,
and hypercholesterolemia
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Table 2 continued
Hu et al,

3614(1921M/1693F)/

2010(Hu et

59178(28842M/30336F)

al., 2010b)

25-74

18.4-year

Low exercise, HR 1.00 (reference)

Age, study year, education, smoking,

Moderate exercise,

alcohol consumption, history of MI,

Male, HR 0.79 (0.68-0.92)

valvular heart disease, DM, SBP, total

Female, HR 0.86 (0.75-0.99)

cholesterol, and BMI

High exercise,
Male, HR 0.69 (0.60-0.80)
Female, HR 0.68 (0.59-0.78)
*The number of subjects are those were finally included in the analyses.
Abbreviations: BMI=body mass index, CHD=coronary heart disease, DM=diabetes mellitus, MI=myocardial infarction, SBP=systolic blood
pressure.
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7,495 participants of the Multifactor Primary Prevention Study,in which the association of coffee
consumption with HF were first studied in bivariate analysis and further studied in multiple
logistic regression.(Wilhelmsen et al., 2001) Coffee consumption was classified into three
categories: 0, 1-4, ≥5cups/day in the bivariate analysis. Result of this analysis indicated that
coffee consumption is marginally associated with HF risk. When entered the multiple logistic
regression model, coffee consumption was analyzed as a variable of two category (<5 cups/day
and ≥5cups/day). Results of this analysis suggested that coffee consumption ≥5cups/day (relative
risk = 1.17; 95% confidence interval [CI], 1.05-1.30, compared with coffee consumption <5
cups/day) was an independent predictor of HF.(Wilhelmsen et al., 2001) In a cohort of Swedish
men, a prospective cohort of 37,315 men aged 45-79 years old, Ahmed et al.(Ahmed et al., 2009)
classified coffee consumption into five categories: <1 cup/day, 2 cups/day, 3 cups/day, 4
cups/day and ≥ 5 cups/day. They did not find a significant association between coffee
consumption and HF hospitalization and HF mortality. Furthermore, the authors conducted a 4
degree of freedom likelihood ratio test to exam whether including coffee consumption added
information to the model. Result of this likelihood ratio test confirmed that coffee consumption
was not a significant predictor of HF events.(Ahmed et al., 2009) Results from the two previous
studies were inconsistent.(Ahmed et al., 2009; Wilhelmsen et al., 2001) Also, both studies were
conducted in men, and it is unclear whether coffee consumption is an independent risk factor of
HF in women. The Finnish population has the highest per capita coffee consumption in the

world, at 11.4 kg/year.(World Resources Institute) Research into the potential health effects
of coffee in this population is therefore of particular interest.
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Lifestyle pattern and HF
The respective influence of lifestyle factors on the risk of HF has been assessed in
several studies. However, the joint association of lifestyle factors with the risk of HF remains
unclear. There is only one recent cohort study which demonstrated that having a healthy
lifestyle had a statistically independent association with a reduced lifetime risk of
HF.(Djousse et al., 2009) This study was conducted on male physicians who certainly had
higher health consciousness, which limited its generalizability. Further studies are needed in
explaining the influence of modifiable lifestyle factors on the risk of HF in other populations.
Also, it is unknown that if the joint associations between lifestyle factors and the risk of heart
failure in people with underlying hypertension is similar with that in the general population.
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CHAPTER 2. OCCUPATIONAL, COMMUTING AND LEISURE-TIME PHYSICAL
ACTIVITY IN RELATIONS TO HEART FAILURE AMONG FINNISH MEN AND
WOMEN2
2.1 Introduction
Heart Failure (HF) has emerged as a scourge throughout the developed and developing
regions of the world (Nieminen and Harjola, 2005; Schocken et al., 2008a). According to the
American Heart Association, 550,000 new cases occur in the U.S. each year, and more than
5 million Americans have HF (Schocken et al., 2008a). Although there is strong evidence
that regular physical activity has a protective effect against coronary heart disease and stroke
(Bassuk and Manson, 2005), studies related to regular physical activity and HF are sparse,
and the results of these studies are inconsistent (Djousse et al., 2009; He et al., 2001;
Kenchaiah et al., 2009). Furthermore, physical activity has always been represented by
leisure-time physical activity in studies related to the association between physical activity
and HF (Djousse et al., 2009; He et al., 2001; Kenchaiah et al., 2009), whereas the
relationship of HF with occupational or commuting physical activity remains unclear. The
aim of this study is to examine whether occupational, commuting, or leisure-time physical
activity are independently associated with a reduced HF risk, and moreover, how different
combinations of physical activity affects the risk.

2.2 Methods
Subjects
Seven independent population surveys were carried out in 6 geographic areas of Finland
2

This chapter originally appeared as Yujie Wang, Jaakko Tuomilehto, Pekka Jousilahti, Riitta Antikainen, Markku
Mähönen, Peter T. Katzmarzyk, and Gang Hu. Occupational, commuting and leisure-time pphysical activity in relation to
heart failure among Finnish men and women. Journal of the American College of Cardiology, 56(14), 1140-1148, 2010.
Reprinted by permission of Elsevier. http://content.onlinejacc.org/article.aspx?articleid=1143710
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in 1972, 1977, 1982, 1987, 1992, 1997 and 2002 (Vartiainen et al., 2000). In 1972 and 1977,
a randomly selected sample of 6.6% of the population born between 1913 and 1947 was
drawn. Since 1982, the sample was stratified by area, gender and 10-year age group
according to the World Health Organization (WHO) Monitoring trends and determinants of
Cardiovascular disease (MONICA) protocol (Pajak et al., 1988). The participation rate
varied by year from 65% to 88% (Vartiainen et al., 2000). The subjects included in the seven
surveys were 25 to 64 years of age, and the 1997 and 2002 surveys also included subjects
aged 65 to 74 years. Subjects who participated in more than one survey were included only
in the first survey cohort in which they appeared. The total sample size of the seven surveys
was 62,013. After excluding 998 subjects with a history of HF at baseline, and 2807 with
incomplete data on any required variables, the present analyses include 28,334 men and
29,874 women. The participants provided an informed consent (verbal 1972-1992 and
written 1997 and 2002). These surveys were conducted according to the ethical rules of the
National Institute for Health and Welfare, and the investigations were performed in
accordance with the Declaration of Helsinki.
Assessment of physical activity
Occupational, commuting, and leisure-time physical activity levels were assessed using
a self-administered questionnaire only at baseline. A detailed description of the questions has
been presented elsewhere (Hu et al., 2004b; Hu et al., 2007a; Hu et al., 2003; Hu et al.,
2005b). The questionnaire used for the assessment of physical activity has been successfully
used elsewhere and it has shown a high correlation with physical fitness, as measured by
maximal oxygen uptake.(Albanes et al., 1990; Andersen et al., 2000) The subjects reported
17

their occupational physical activity according to the following three categories: (i) ‘low’ was
physically very easy, sitting office work, e.g. secretary; (ii) ‘moderate’ was work including
standing and walking, e.g. store assistant, light industrial worker; (iii) ‘high’ was work
including walking and lifting, or heavy manual labor, e.g. industrial or farm work. Daily
commuting (return journey) was categorized into three categories: (i) motorized
transportation or no physical work (no walking or cycling); (ii) walking or bicycling 1 to
29 minutes per day; (iii) walking or bicycling more than 30 minutes per day. Self-reported
leisure-time physical activity was classified into three categories: (i) ‘low’ was defined as
almost completely inactive, such as reading, watching TV, or doing some minor physical
activity but not of moderate or high level; (ii) ‘moderate’ was doing some physical activity
more than four hours a week, such as walking, cycling, or light gardening, excluding travel
to work; (iii) ‘high’ was performing vigorous physical activity more than three hours a week,
such as running, jogging, swimming, or heavy gardening, or competitive sports several times
a week.
Other assessments
Smoking, socioeconomic factors, alcohol consumption, and medical history were also
assessed by using the self-administered questionnaire. Based on the questionnaire data, the
participants were classified as never smokers, ex-smokers and current smokers. Current
smokers were categorized into those who smoked <20 or ≥20 cigarettes per day. Years of
education were divided into birth cohort specific tertiles. Since questions on alcohol
consumption were different between the first two surveys (1972 and 1977) and the latter
surveys, the participants were categorized into abstainers and alcohol users. Data on the
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initiation of antihypertensive drug treatment were obtained from the questionnaire and the
records of drug register. Subjects who reported having diabetes on the questionnaire, or who
had had a hospital discharge diagnosis of diabetes (including asymptomatic diabetes and
known diabetes), or who received the approval of a physician for using diabetes medication
(either oral glucose-lowering agents or insulin) before the baseline survey were classified as
having history of diabetes at baseline (Hu et al., 2003). Data on the history of myocardial
infarction at baseline were obtained from the questionnaire and collected by hospital
discharge diagnosis, and the overall sensitivity of the diagnosis of myocardial infarction in
the FINNISH Hospital Discharge Register was 83% (Pajunen et al., 2005). Data on the
history of valvular heart disease at baseline were collected by hospital discharge register.
Data on the history of lung disease (pulmonary emphysema, bronchitis, chronic bronchial
catarrh) were collected from the questionnaire.
At the study site, trained research nurses measured height, weight, and blood pressure
using a standardized protocol (Pajak et al., 1988). Height was measured without shoes and
weight was measured with light clothing. Body mass index (BMI) was calculated by
dividing weight in kilograms by the square of height in meters. Blood pressure was measured
from the right arm after five minutes of sitting. After blood pressure measurement, a venous
blood specimen was taken. Total cholesterol was determined by using Lieberman Burchard
method in 1972 and 1977 and by an enzymatic method (CHOD-PAP, Boehringer
MANNHEIM, Mannheim, Germany) since 1982. Because the enzymatic method gave 2.4%
lower values than the Lieberman Burchard method (based on the double measurements of
serum samples during the change of laboratory method), the values measured in 1972 and
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1977 were corrected by this percentage. All samples were analyzed in the same central
laboratory.
Prospective Follow-up
Follow-up information was obtained from the Finnish Hospital Discharge Register and
the National Social Insurance Institution’s Register on special reimbursement for HF drugs
for non-fatal outcomes and the Finnish Death Register for fatal outcomes by using social
security numbers assigned to every citizen of Finland. The International Classification of
Diseases (ICD) codes 427.00 and 427.10 (ICD-8), 428, 4029B (hypertensive heart disease
with HF) and 4148A-X (ischemic HF with chronic coronary heart disease) (ICD-9), and I 50,
I11.0 (hypertensive heart disease with HF), I13.0 and I13.2 (hypertensive heart and renal
disease with HF) (ICD-10) were used to identify cases in the above national databases. A HF
diagnosis was made by the treating physicians, based on a clinical assessment, X-ray
examination and, to various extents, echocardiography. Follow-up of each cohort member
continued until the date of the diagnosis of HF obtained from the Hospital Discharge
Register, the National Social Insurance Institution’s Register or mortality, death from causes
other than HF, or December 31, 2006 (Hu et al., 2010a). This diagnosed method has been
used in other Scandinavian countries, such as Sweden. The accuracy of the HF cases in the
Swedish hospital discharge is found to be over 80% based on the European Society of
Cardiology (ESC) definition.(Ingelsson et al., 2005a; Levitan et al., 2009a)
Statistical analyses
Differences in risk factors between groups with different physical activity levels were
tested using univariate analysis of variance (ANOVA) after adjustment for age and study
20

year. Cox proportional hazards regression models were used to analyze the association of
physical activity with the risk of HF. Physical activity categories were included in the
models as dummy and categorical variables, and the significance of the trend over different
categories of physical activity was tested in the same models by giving an ordinal numeric
value for each dummy variable. The proportional hazards assumption in the Cox model was
assessed with graphical methods, and with models including time-by-covariate interactions
(Cox, 1972). In general, all proportionality assumptions were appropriate. The analyses were
first carried out adjusting for age and study year, and further for smoking, education, alcohol
consumption, history of myocardial infarction, history of valvular heart disease, history of
diabetes, history of using anti-hypertensive drugs, history of lung disease, BMI, systolic
blood pressure, and total cholesterol, and further for other two types of physical activity. To
avoid a potential bias due to severe disease at baseline, additional analyses were carried out
excluding the subjects who died during the first two years of follow-up (n=408). Statistical
significance was considered to be P<0.05. Statistical package SPSS for Windows, version
17.0 (SPSS Inc, Chicago, III), was used for statistical analysis.

2.3 Results
During a mean follow-up of 18.4 years, 1868 men and 1640 women developed HF.
General characteristics of the study population by different types of physical activity at
baseline are presented in Table 3. Age- and study year-adjusted partial correlations were 0.23
in men (P<0.001) and 0.20 in women (P<0.001) for occupational and commuting physical
activity, -0.08 in men (P<0.001) and -0.04 in women (P<0.001) for occupational and
leisure-time physical activity, and 0.03 in men (P<0.001) and 0.06 in women (P<0.001) for
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commuting and leisure-time physical activity.
Age- and study year-adjusted hazard ratios (HRs) of HF associated with low, moderate
and high occupational physical activity were 1.00, 0.75, and 0.74 (P<0.001 for trend) for
men, and 1.00, 0.67, and 0.87 (P<0.001 for trend) for women, respectively (Table 4). In
multivariable analyses, after further adjustment for other risk factors (smoking, education,
alcohol consumption, history of myocardial infarction, history of valvular heart disease,
history of diabetes, history of using anti-hypertensive drugs, history of lung disease, BMI,
systolic blood pressure, and total cholesterol), and for commuting and leisure-time physical
activity, these inverse associations were still statistically significant for men (P=0.005 for
trend) and women (P=0.007 for trend).
Daily commuting physical activity on foot or by bicycle was significantly and inversely
associated with the risk of HF among men (P<0.001 for trend) and women (P<0.001 for
trend) after adjustment for age and study year (Table 5). The inverse relationship remained
significant among women (P=0.008 for trend) but not among men (P=0.374 for trend) after
further adjustment for other risk factors. Women spending daily 1-29 minutes in walking or
cycling to and from work had a significantly reduced risk of HF than women who had no
commuting activity after additional adjustment for occupational and leisure-time physical
activity.
Age- and study year-adjusted HRs of HF associated with low, moderate and high
leisure-time physical activity were 1.00, 0.81, and 0.53 (P<0.001 for trend) in men, and 1.00
0.71, and 0.56 (P<0.001 for trend) in women, respectively (Table 6). These inverse
associations weakened to some extent, but remained statistically significant, after further
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Table 3. General characteristics of study subjects at baseline*
Occupational physical
Men

activity

P for

Low

Moderate

High

11,069

6,032

11,233

Age at baseline (yrs)

48.5

42.2

43.0

Body mass index (kg/m2)

26.5

26.4

Diastolic blood pressure (mm Hg)

87

Systolic blood pressure (mm Hg)

trend

Women

P for
trend

Low

Moderate

High

13,115

9,266

7,493

<0.001

46.8

42.4

44.2

<0.001

26.3

0.003

26.0

25.7

26.6

<0.001

87

86

0.002

83

83

84

<0.001

143

142

143

<0.001

138

137

140

<0.001

Serum cholesterol (mmol/l)

6.01

6.04

6.19

<0.001

5.96

5.89

6.09

<0.001

Education (yrs)

10.4

10.6

8.3

<0.001

10.3

10.6

9.1

<0.001

Alcohol drinker (%)

66.3

77.1

63.6

<0.001

40.6

43.4

32.0

<0.001

Current smoker (%)

41.8

36.6

43.2

<0.001

19.3

18.7

16.3

<0.001

History of myocardial infarction (%)

5.5

2.8

1.9

<0.001

1.6

0.6

0.4

<0.001

No. of subjects
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Table 3 continued
History of valvular heart disease (%)

0.1

0.2

0.1

0.36

0.1

0.1

0.0

0.013

History of diabetes (%)

3.3

2.4

1.7

<0.001

2.6

1.4

1.7

<0.001

History of using anti-hypertensive drugs (%)

12.3

9.5

7.9

<0.001

13.6

9.5

9.9

<0.001

History of lung disease (%)

7.5

4.5

5.3

<0.001

5.1

4.6

4.9

0.261

Commuting physical activity
Men

P for

0

1-29

≥30

15,288

8,565

4,481

Age at baseline (yrs)

46.2

42.2

46.0

Body mass index (kg/m2)

26.5

26.3

Diastolic blood pressure (mm Hg)

87

Systolic blood pressure (mm Hg)
Serum cholesterol (mmol/l)

No. of subjects

Women

P for

0

1-29

≥30

13,650

9,609

6,615

<0.001

47.1

42.1

43.9

<0.001

26.1

<0.001

26.5

25.8

25.6

<0.001

87

87

0.63

83

83

83

0.33

143

142

142

<0.001

139

137

137

<0.001

6.10

6.09

6.07

0.22

6.02

5.92

5.94

<0.001

trend
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trend

Table 3 continued
Education (yrs)

9.4

10.0

9.6

<0.001

9.6

10.5

10.4

<0.001

Alcohol drinker (%)

65.7

67.5

65.8

0.012

35.0

44.0

41.5

<0.001

Current smoker (%)

43.5

38.1

39.6

<0.001

18.3

19.0

17.7

0.093

History of myocardial infarction (%)

4.6

2.2

2.1

<0.001

1.5

0.6

0.5

<0.001

History of valvular heart disease (%)

0.1

0.2

0.1

0.46

0.1

0.0

0.1

0.049

History of diabetes (%)

2.7

2.1

2.5

0.009

2.5

1.6

1.2

<0.001

History of using anti-hypertensive drugs (%)

10.9

9.2

8.7

<0.001

13.1

10.3

9.5

<0.001

History of lung disease (%)

6.9

4.9

4.9

<0.001

5.1

4.6

4.9

0.158

Leisure-time physical activity
Men

Women

Low

Moderate

High

Low

Moderate

High

No. of subjects

7,849

14,761

5,724

10,564

15,032

4,278

Age at baseline (yrs)

45.5

46.3

41.0

45.7

45.2

41.3

<0.001
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<0.001

Table 3 continued
Body mass index (kg/m2)

26.7

26.5

25.7

<0.001

26.9

25.8

25.0

<0.001

Diastolic blood pressure (mm Hg)

87

87

85

<0.001

84

83

82

<0.001

Systolic blood pressure (mm Hg)

143

143

141

<0.001

139

138

136

<0.001

Serum cholesterol (mmol/l)

6.15

6.14

5.88

<0.001

6.01

5.96

5.90

<0.001

Education (yrs)

9.1

9.5

10.6

<0.001

9.7

10.2

10.7

<0.001

Alcohol drinker (%)

63.1

66.8

69.3

<0.001

36.5

39.8

44.6

<0.001

Current smoker (%)

50.0

41.8

27.8

<0.001

21.6

17.8

12.4

<0.001

History of myocardial infarction (%)

3.9

3.7

2.5

<0.001

1.4

0.9

0.5

<0.001

History of valvular heart disease (%)

0.1

0.2

0.1

0.060

0.1

0.1

0.1

0.74

History of diabetes (%)

3.2

2.3

1.8

<0.001

2.3

1.9

1.1

<0.001

History of using anti-hypertensive drugs (%)

10.7

10.4

7.7

<0.001

13.1

11.0

8.1

<0.001

History of lung disease (%)

7.7

5.6

4.6

<0.001

5.7

4.6

3.9

<0.001

*Baseline characteristics represent mean or percentage; adjusted for age and study year.
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Table 4. Hazard ratios of heart failure according to different levels of occupational physical activity
Occupational physical

activity

P for trend

Low

Moderate

High

11,069

6,032

11,233

777

340

751

160,376

117,247

225,292

Age and study years adjusted HR (95% CI)

1.00

0.75 (0.66-0.85)

0.74 (0.67-0.82)

<0.001

Multivariable adjustment HR (95% CI)*

1.00

0.88 (0.77-1.01)

0.84 (0.75-0.94)

0.006

Multivariable adjustment HR (95% CI)†

1.00

0.90 (0.78-1.03)

0.83 (0.73-0.93)

0.005

13,115

9,266

7,493

759

358

523

216,737

189,921

159,959

Age and study years adjusted HR (95% CI)

1.00

0.67 (0.59-0.76)

0.87 (0.78-0.97)

<0.001

Multivariable adjustment HR (95% CI)*

1.00

0.77 (0.67-0.87)

0.90 (0.80-1.01)

<0.001

Men
No. of incidence case
Person-yrs

Women
No. of incidence case
Person-yrs
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Table 4 continued
Multivariable adjustment HR (95% CI)†

1.00

0.80 (0.70-0.92)

0.92 (0.82-1.05)

24,184

15,298

18,726

1,536

698

1,274

377,113

307,168

385,251

Age and study years adjusted HR (95% CI)

1.00

0.70 (0.64-0.77)

0.79 (0.74-0.85)

<0.001

Multivariable adjustment HR (95% CI)*

1.00

0.82 (0.74-0.90)

0.86 (0.79-0.93)

<0.001

Multivariable adjustment HR (95% CI)†

1.00

0.85 (0.77-0.93)

0.87 (0.80-0.94)

<0.001

Men and women combined‡
No. of incidence case
Person-yrs

0.007

HR = hazard ratio; CI = confidence interval.
*Adjusted for age, study year, education, smoking, alcohol consumption, history of myocardial infarction, history of valvular heart disease,
history of diabetes, systolic blood pressure, total cholesterol, history of using anti-hypertension drugs, history of lung disease and BMI.
†Adjusted for age, study year, education, smoking, alcohol consumption, history of myocardial infarction, history of valvular heart disease,
history of diabetes, systolic blood pressure, total cholesterol, history of using anti-hypertensive drugs, history of lung disease, BMI, and other
two types of physical activity.
‡Adjusted also for sex.
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Table 5. Hazard ratios of heart failure according to different levels of commuting physical activity
Walking or cycling to and from work (minutes/day)

P for trend

0

1-29

≥30

15,288

8,565

4,481

984

499

385

243,541

167,513

91,861

Age and study years adjusted HR (95% CI)

1.00

0.83 (0.74-0.92)

0.81 (0.72-0.91)

<0.001

Multivariable adjustment HR (95% CI)*

1.00

0.96 (0.86-1.07)

0.92 (0.81-1.04)

0.374

Multivariable adjustment HR (95% CI)†

1.00

1.01 (0.90-1.13)

0.99 (0.87-1.12)

0.954

13,650

9,609

6,615

959

351

330

237,004

192,706

136,906

Age and study years adjusted HR (95% CI)

1.00

0.73 (0.64-0.82)

0.76 (0.67-0.86)

<0.001

Multivariable adjustment HR (95% CI)*

1.00

0.83 (0.73-0.94)

0.89 (0.78-1.01)

0.008

Men
No. of incidence case
Person-yrs

Women
No. of incidence case
Person-yrs
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Table 5 continued
Multivariable adjustment HR (95% CI)†

1.00

0.87 (0.76-0.99)

0.94 (0.82-1.07)

28,938

18,174

11, 096

1,943

850

715

480,545

360,220

228,767

Age and study years adjusted HR (95% CI)

1.00

0.77 (0.71-0.83)

0.76 (0.70-0.83)

<0.001

Multivariable adjustment HR (95% CI)*

1.00

0.88 (0.81-0.96)

0.88 (0.80-0.96)

0.001

Multivariable adjustment HR (95% CI)†

1.00

0.93 (0.85-1.01)

0.93 (0.85-1.02)

0.159

Men and women combined‡
No. of incidence case
Person-yrs

0.108

HR = hazard ratio; CI = confidence interval.
*Adjusted for age, study year, education, smoking, alcohol consumption, history of myocardial infarction, history of valvular heart disease,
history of diabetes, systolic blood pressure, total cholesterol, history of using anti-hypertension drugs, history of lung disease and BMI.
†Adjusted for age, study year, education, smoking, alcohol consumption, history of myocardial infarction, history of valvular heart disease,
history of diabetes, systolic blood pressure, total cholesterol, history of using anti-hypertensive drugs, history of lung disease, BMI, and other
two types of physical activity.
‡Adjusted also for sex.
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Table 6. Hazard ratios of heart failure according to different levels of leisure time physical activity
Leisure time physical activity

P for trend

Low

Moderate

High

7,849

14,761

5,724

707

995

166

140,606

260,215

102,094

Age and study years adjusted HR (95% CI)

1.00

0.81 (0.73-0.88)

0.53 (0.45-0.62)

<0.001

Multivariable adjustment HR (95% CI)*

1.00

0.84 (0.76-0.93)

0.66 (0.55-0.79)

<0.001

Multivariable adjustment HR (95% CI)†

1.00

0.83 (0.76-0.92)

0.65 (0.54-0.77)

<0.001

10,564

15,032

4,278

940

608

92

219,722

273,837

73,058

Age and study years adjusted HR (95% CI)

1.00

0.71 (0.65-0.79)

0.56 (0.46-0.69)

<0.001

Multivariable adjustment HR (95% CI)*

1.00

0.83 (0.74-0.92)

0.74 (0.59-0.92)

<0.001

Men
No. of incidence case
Person-yrs

Women
No. of incidence case
Person-yrs
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Table 6 continued
Multivariable adjustment HR (95% CI)†

1.00

0.84 (0.75-0.93)

0.75 (0.60-0.94)

18,413

29,793

10,002

1,647

1,603

258

360,328

534,052

175,151

Age and study years adjusted HR (95% CI)

1.00

0.75 (0.70-0.81)

0.54 (0.48-0.61)

<0.001

Multivariable adjustment HR (95% CI)*

1.00

0.83 (0.77-0.89)

0.69 (0.60-0.79)

<0.001

Multivariable adjustment HR (95% CI)†

1.00

0.83 (0.77-0.89)

0.69 (0.60-0.79)

<0.001

Men and women combined‡
No. of incidence case
Person-yrs

0.001

HR = hazard ratio; CI = confidence interval.
*Adjusted for age, study year, education, smoking, alcohol consumption, history of myocardial infarction, history of valvular heart disease,
history of diabetes, systolic blood pressure, total cholesterol, history of using anti-hypertension drugs, history of lung disease and BMI.
†Adjusted for age, study year, education, smoking, alcohol consumption, history of myocardial infarction, history of valvular heart disease,
history of diabetes, systolic blood pressure, total cholesterol, history of using anti-hypertensive drugs, history of lung disease, BMI, and other
two types of physical activity.
‡Adjusted also for sex.
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Figure 1. Hazard rations of heart failure according to joint categories of occupational, commuting andleisure-time physical activity among men
(A) and women (B).
Adjusted for age, study year, education, smoking, alcohol consumption, history of myocardial infarction, history of valvular heart disease,
history of diabetes, history of using anti-hypertensive drugs, history of lung disease BMI, systolic blood pressure, and total cholesterol.
*p<0.05
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adjustment for other risk factors and occupational and commuting physical activity (both
P<0.001 for trend).
The joint effects of different types of physical activity on the risk of HF are presented in
Figure 1. We dichotomized the level of occupational and leisure-time physical activity at low
versus moderate to high and the level of commuting physical activity as any versus none.
Among men, both moderate or high levels of leisure-time physical activity and moderate or
high levels of occupational physical activity had inverse associations with HF risk. The
combination of any two types of physical activity or the made this favorable effect even
bigger. Among women, none of the three types of physical activity alone is significantly
associated with a reduced risk of HF. However, the risk of HF significantly reduced among
women with more than one type of physical activity. After adjustment for age, study year,
and other risk factors, men with high levels of all three types of physical activity had a 31%
lower risk of HF as compared with the least active men. In women, the risk reduction was
34%.
Exclusion of the participants who died during the first two years of follow-up did not
appreciably change the results above.

2.4 Discussion
Moderate and high levels of occupational or leisure-time physical activity are associated
with a reduced risk of HF in both sexes. Commuting activity was inversely associated with
HF risk among women before adjustment for occupational and leisure time physical activity.
A simultaneous engagement in two or three types of physical activity showed a slightly
stronger protective effect than participation in only one type of physical activity.
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To the best of our knowledge, only three studies have assessed the association between
physical activity and the risk of HF (Djousse et al., 2009; He et al., 2001; Hu et al., 2010a;
Kenchaiah et al., 2009), and only one of them included both men and women (He et al.,
2001). Moreover, the results of the three studies were inconsistent.(Djousse et al., 2009; He
et al., 2001; Hu et al., 2010a; Kenchaiah et al., 2009) Physical activity was found to be a
protective factor against HF among men in the Physicians’ Health Study.(Djousse et al.,
2009; Kenchaiah et al., 2009) On the other hand, in the First National Health and Nutrition
Examination Survey, the significant inverse association between leisure-time physical
activity and HF risk was found only in women but not in men(He et al., 2001). In the present
study, for the first time, moderate or high physical activity levels were found to be associated
with a decreased risk of HF in both men and women.
All of the previous studies focused on leisure-time activity. (Djousse et al., 2009; He et
al., 2001; Kenchaiah et al., 2009) However, the present study shows for the first time that
moderate or high occupational physical activity also has the same protective effect on the
risk of HF as leisure-time physical activity, especially in men. If this finding represents a
causal relation, this approach is highly relevant to the improvement of health and longevity
among working-aged people, because the increase in computerization and mechanization
during the last decades has resulted in ever-increasing numbers of people being sedentary for
most of their working time. Occupational physical activity has been largely ignored in
epidemiological surveys. The National Institutes of Health Consensus Development
Conference on Physical Activity and Cardiovascular Health concluded that intermittent or
shorter bouts of physical activity (at least 10 minutes), including occupational and
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non-occupational activity and tasks of daily living, have similar HF preventive effects and
other health benefits if performed at a level of moderate intensity (such as brisk walking,
cycling, swimming, home repair, and yard work) with an accumulated duration of at least 30
minutes per day (NIH Consensus Development Panel on Physical Activity and
Cardiovascular Health, 1996).
The present study is also the first study which observed an association between
commuting physical activity and the risk of HF. We observed the significant inverse
association between active commuting with the risk of HF events in women before
adjustment for occupational and leisure time physical activity. Although we did not establish
a significant association between the risk of HF and commuting physical activity alone in
both men and women, we confirmed that an individual with moderate or high leisure-time or
occupational physical activity experienced further reduced risk of HF, when he was also
engaged in commuting physical activity. This is an important finding because daily active
commuting is a major source of total physical activity in some populations, can be
implemented virtually everywhere, and is inexpensive. For example, in urban China more
than 90% of people walk or cycle to and from work daily (Hu et al., 2002) . In our study,
54% of women and 46% of men reported walking or cycling to work daily, and 22% of
women and 16% of men reported more than a half hour walking or cycling to work daily.
Several studies have shown that regular walking or cycling to and from work is related to
lower levels of cardiovascular risk factors (Hu et al., 2001; Hu et al., 2002; Hu et al., 2003),
as well as a reduced risk of type 2 diabetes (Hu et al., 2003), stroke (Hu et al., 2005b), and
CHD incidences (Hu et al., 2007a), and mortality in general populations and patients with
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diabetes (Andersen et al., 2000; Hu et al., 2004b). In many Western studies, commuting
physical activity was indirectly measured by asking for the frequency and duration of
walking or cycling. Our results emphasize commuting as a separate component of physical
activity to prevent HF in women.
The differences between the results of the present study and the previous studies may be
partially explained by the relatively larger sample size of both men and women; the inclusion
of physical activity during occupation, commuting, and leisure time; more incident HF cases;
and different adjustment procedures in the present study. When assessing the joint effects of
different types of physical activity, we observed a slightly higher risk of HF in those who
participated in three types of physical activity. By our classification, it was possible that the
level of the three types of physical activity in which those participants engaged were
moderate levels of physical activity, while it is also possible for participants to take part in
two types of physical activity the level of which were high levels of physical activity. This
may partly account for the observed trend. Moreover, the present study indicated that the
lowest hazard ratios occurred in women who did moderate occupational and commuting
physical activity. Older age and higher levels of CVD risk factors in women with high
occupational physical activity compared with women with moderate occupational physical
activity may partly account for the observed trend although we took these CVD risk factors
into account in the multivariable analyses. Except for older age, other possible reasons for
the loss of dose effect between commuting physical activity and HF risk among women in
our study was unknown.
The protective effect of physical activity to HF may be partly mediated by its effect on
38

other risk factors for HF. Physical activity has a favorable effect on blood pressure, lipid
profile, insulin sensitivity, body weight, blood coagulation, and fibrinolysis (Gris et al., 1990;
Hu et al., 2004a; Hu et al., 2007a; Hu et al., 2001; Hu et al., 2002; Mayer-Davis et al., 1998),
and it is also contributed to a decreased risk of developing hypertension, type 2 diabetes, the
metabolic syndrome and CHD (Hu et al., 2004a; Hu et al., 2007a; Hu et al., 2003; Hu et al.,
2007c; Laaksonen et al., 2002; Tuomilehto et al., 2001). In our study population, it has been
previously shown that moderate or high levels of occupational or leisure-time physical
activity were associated with a reduced risk of CHD, and daily walking or cycling to and
from work was associated with a decreased risk of CHD among women (Hu et al., 2007a; Hu
et al., 2007c). The current findings on the relationship between physical activity and the risk
of HF are similar with the previous findings about the association between physical activity
and the risk of CHD.

In the present study, the inverse association between physical activity

and the risk of HF remained after adjusting for major HF risk factors. However, given the
temporal lag between the assessment of physical activity at baseline and the measurement of
the outcome, it is not possible to determine the pathways by which physical activity resulted
in lower risk of HF.
There are several strengths and limitations in our study. First, a major strength of the
study is the large number of both men and women from a homogeneous population who
participated in the study. Second, the mean follow-up time was sufficiently long to ascertain
a large number of HF endpoint events. Not only leisure-time physical activity, but also
occupational and commuting physical activities were included in the analysis. Finally, we
also carried out additional analyses excluding the subjects who died during the first two
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years of follow-up to avoid a potential bias due to a severe disease at baseline. A limitation
of our study is the self-report of physical activity, and that physical activity was recorded
only once at baseline. Although no specific assessment of repeatability or validity of our
questionnaire for physical activity has been carried out, similar questionnaires have been
used in a large number of studies in Finland and other Nordic countries (Andersen et al.,
2000; Hu et al., 2004b; Hu et al., 2007a; Hu et al., 2003; Hu et al., 2005b) where the patterns
of physical activity are relatively similar. The method has been working in a large number of
studies that can be considered as a validation in practice.(Albanes et al., 1990; Andersen et
al., 2000) We have no data on possible changes in physical activity during the follow-up.
Misclassification, particularly over-reporting of the amount of physical activity at baseline
and changes in the activity during the follow-up probably underestimated the association
between physical activity and the outcome. Because our data allowed for only a
dichotomized measure of alcohol consumption in the whole sample, we may not be able to
fully control for the effect of this variable on the risk of HF. In order to evaluate the impact
of this shortcoming we performed separate subgroup analyses (surveys of 1982, 1987, 1992,
1997 and 2002) in the multivariable-adjusted model of a dichotomized measure of alcohol
consumption compared with another multivariable-adjusted model of 4 categories of alcohol
consumption. In general, the associations between different types of physical activity and HF
risk were not influenced substantially or systematically. Ascertainment of HF status was
based on the National Hospital Discharge Registry, the National Social Insurance
Institution’s Register on special reimbursement for HF drugs, and Causes of Death Register.
This diagnosis method has been used in other Scandinavian countries, such as Finland and
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Sweden (Hu et al., 2010a; Ingelsson et al., 2005a; Levitan et al., 2009a; Wang et al., 2009).
The accuracy of the HF cases in the Swedish hospital discharge is found to be over 80%
based on the ESC definition (Ingelsson et al., 2005a; Levitan et al., 2009a). Although
accuracy of clinical HF diagnosis in our cohort is likely to be high, some diagnostic errors
are inevitable. However, the misdiagnosis is most likely to be independent of the exposure
status and therefore tends to attenuate the underlying associations rather than cause spurious
associations. We cannot completely either exclude the effects of residual confounding due to
measurement error in the assessment of confounding factors, or some unmeasured

factors,

such as other chronic diseases (e.g., peripheral vascular disease, renal disease, and anemia),
the extent or severity of the prior MI, ischemic heart disease symptom burden, and some
dietary factors.
In conclusion, our study confirms that moderate or high levels of occupational or
leisure-time physical activity have negative association with the risk of HF among men and
women. Active commuting had a significant inverse association with the risk of HF events in
women before adjustment for occupational and leisure time physical activity.
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CHAPTER 3. COFFEE CONSUMPTION AND THE RISK OF HEART FAILURE IN
FINNISH MEN AND WOMEN3
3.1 Introduction
Heart failure (HF) has emerged as a major and growing health problem both in the
developed and developing regions of the world.(Schocken et al., 2008a) Although use of
medication has reduced re-hospitalization rates and mortality from HF, HF is still the leading
cause of hospitalization for older people in the United States,(Kozak et al., 2006) and
mortality among HF patients has remained substantial, with approximately one quarter of
patients dying within one year and half within five years of diagnosis. Therefore, the
prevention of HF through lifestyle approaches is an important public health consideration.
Coffee is one of the most widely consumed beverages in the world.(Popkin et al., 2006)
It has been suggested that coffee consumption may be associated with the risk of coronary
heart disease (CHD),(Wu et al., 2009) hypertension,(Noordzij et al., 2005) and type 2
diabetes.(Tuomilehto et al., 2004; van Dam and Hu, 2005) Two prospective studies have
previously investigated the association between coffee consumption and HF risk among
Swedish men.(Ahmed et al., 2009; Wilhelmsen et al., 2001) One showed that coffee
consumption increased the risk of HF,(Wilhelmsen et al., 2001) while the other found an null
association between coffee consumption and the risk of HF.(Ahmed et al., 2009) Also, both
studies were conducted in men, and it is unclear whether coffee consumption is an independent
risk factor of HF in women. The Finnish population has the highest per capita coffee

consumption in the world, at 11.4 kg/year.(World Resources Institute) Therefore, the aim of
3

This chapter originally appeared as Yujie Wang, Jaakko Tuomilehto, Pekka Jousilahti, Riitta Antikainen, Markku
Mähönen, Satu Männistö, Peter T. Katzmarzyk, and Gang Hu. Coffee consumption and the risk of heart failure in Finnish
men and women. Heart, 97(1), 44-48, 2010. Reprinted by permission of BMJ Group.
http://heart.bmj.com/content/early/2010/10/26/hrt.2010.206045
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this study was to examine the association of coffee consumption with the risk of HF in a
large prospective cohort of Finnish men and women.

3.2 Methods
Subjects
Seven independent cross-sectional population surveys were carried out in six geographic
areas of Finland in 1972, 1977, 1982, 1987, 1992, 1997 and 2002.(Vartiainen et al., 2000) In
1972 and 1977, a randomly selected sample making up 6.6% of the population born between
1913 and 1947 was drawn. Since 1982, the sample was stratified by area, gender and 10-year
age group according to the World Health Organization (WHO) MONICA (MONItoring trends
and determinants of CArdiovascular disease) protocol.(Pajak et al., 1988) The participation
rate varied by year from 65% to 88%.(Vartiainen et al., 2000) The subjects included in the
seven surveys were 25 to 64 years of age, and the 1997 and 2002 surveys also included
subjects aged 65 to 74 years. Subjects who participated in more than one survey were included
only in the first survey cohort. The total sample size of the seven surveys was 62,013. After
excluding 998 subjects with a history of HF at baseline, and 1525 with incomplete data on any
required variables, the present analyses include 28,837 men and 30,653 women. The
participants provided an informed consent (verbal from 1972 to 1992 and written 1997 and
2002). These surveys were conducted according to the ethical rules of the National Public
Health Institute, and the investigations were performed in accordance with the Declaration of
Helsinki.

43

Baseline measurements
A self-administered questionnaire was mailed to the participants to be completed at home
and returned to the survey site. The questionnaire included questions on medical history,
socioeconomic factors, physical activity, smoking habits, and alcohol consumption. Education
level, measured as the total number of school years, was divided into birth cohort specific
tertiles. Physical activity included occupational, commuting, and leisure time physical
activity. A detailed description of the questions is presented elsewhere.(Hu et al., 2003) The
subjects reported their occupational physical activity according to the following three
categories: light, moderate and active. The daily commuting return journey to work was
grouped into three categories: (i) using motorized transportation, or not working outside home
(0 minutes of walking or cycling); (ii) walking or bicycling 1 to 29 minutes; (iii) walking or
bicycling for more than 30 minutes. Self-reported leisure time physical activity was classified
into three categories: low, moderate and high. Since we found that moderate and high
occupational, commuting or leisure time physical activity independently and significantly
reduces risk of HF (data not shown), the groups were merged into three categories: (i) low was
defined as subjects who reported light levels of occupational, commuting (<1 minute) and
leisure time physical activity; (ii) moderate was defined as subjects who reported only one of
the all three types of moderate to high physical activity; (iii) high was defined as subjects who
reported two or three types of moderate to high physical activity. Participants were also
classified as never, ex- and current-smokers based on their responses to the questionnaire.
Current smokers were categorized into those participants who smoked <20, or ≥20 cigarettes
per day. Since questions on alcohol consumption were different between the first 2 surveys
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(1972 and 1977) and the latter surveys, the participants were categorized into abstainers and
alcohol users. Data on the history of myocardial infarction or diabetes at baseline were
obtained from the questionnaire and collected by hospital discharge or drug register. Data on
the history of valvular heart disease at baseline were collected from the national hospital
discharge register by record linkage.
The participants were asked, “How many cups of coffee or tea do you drink daily (1 cup
of coffee equals to 1 dL; one cup of tea equal to 2 dL)?”(Tuomilehto et al., 2004) Based on
the validation study of the dietary questionnaire carried out in subgroups of the study
population,(Paalanen et al., 2006) the correlations between the dietary questionnaire and
food records for the amount of coffee consumed were 0.89 in men and 0.85 in women.
Coffee consumption was categorized into six categories: 0 cup, 1-2 cups, 3-4 cups, 5-6 cups,
7-9 cups and ≥10 cups per day. As only a few people drank tea, tea consumption was
categorized into three categories: none, 1-2 cups, and ≥3 cups.
At the survey site, specially trained research nurses measured participants’ height and
weight by using the standardized WHO MONICA protocol.(Pajak et al., 1988) Height and
weight were measured without shoes and with light clothing. The measurements of height
were rounded to the nearest centimeter and weight to nearest 100 grams.(Pajak et al., 1988)
Body mass index (BMI) was calculated by dividing weight in kilograms by the square of
height in meters. Blood pressure was measured from the right arm after five minutes of sitting
using a mercury sphygmomanometer in each survey. After blood pressure measurement, a
venous blood specimen was taken. Total cholesterol was determined by using Lieberman
Burchard method in 1972 and 1977 and by an enzymatic method (CHOD-PAP, Boehringer
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MANNHEIM, Mannheim, Germany) since 1982. Because the enzymatic method gave 2.4%
lower values than the Lieberman-Burchard method, the values measured in 1972 and 1977
were corrected by this percentage.(Sundvall et al., 2007) All samples were analyzed in the
same central laboratory at the National Public Health Institute.
Prospective follow-up
Follow-up information was from the Finnish Hospital Discharge Register and the
National Social Insurance Institution’s Register on special reimbursement for HF drugs for
non-fatal outcomes and the Finnish Death Register for fatal outcomes by record linkage using
the personal identification numbers assigned to every citizen of Finland. The International
Classification of Diseases (ICD) codes 427.00 and 427.10 (ICD-8), 428, 4029B (hypertensive
heart disease with HF) and 4148A-X (ischemic HF with chronic CHD) (ICD-9), and I 50,
I11.0 (hypertensive heart disease with HF), I13.0 and I13.2 (hypertensive heart and renal
disease with HF) (ICD-10) were used to identify HF cases in the above-mentioned national
databases. A HF diagnosis was made by the treating physicians, based on a clinical
assessment, X-ray examination and, to various extents echocardiography. Follow-up of each
cohort member continued until the date of the diagnosis of HF from Hospital Discharge
Register, the National Social Insurance Institution’s Register or mortality, death from causes
other than HF, or December 31, 2007. This method to ascertain HF cases in prospective
epidemiological studies has been used in other Scandinavian countries, such as Sweden. The
accuracy of the HF cases in the Swedish hospital discharge is found to be over 80% compared
with the European Society of Cardiology (ESC) definition of HF.(Ingelsson et al., 2005a)
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Statistical analyses
Differences in risk factors at baseline based on different levels of coffee consumption
were tested using General Linear Model after adjustment for age and study year. Cox
proportional hazards regression models were used to analyze the association of coffee
consumption with the risk of HF. Coffee consumption categories were included in the models
as dummy and categorical variables, and the significance of the trend over different categories
of coffee consumption was tested in the same models by giving an ordinal numeric value for
each dummy variable. The proportional hazards assumption in the Cox model was assessed
with graphical methods, and with models including time-by-covariate interactions.(Cox,
1972) In general, all proportionality assumptions were appropriate. The analyses were first
carried out adjusting for age and study year, and further adjusting for smoking, education,
alcohol consumption, tea consumption, physical activity, BMI, systolic blood pressure,
history of myocardial infarction, history of valvular heart disease, history of diabetes, and total
cholesterol. To avoid a potential bias due to severe disease at baseline, additional analyses
were carried out excluding the subjects who died during the first two years of follow-up
(n=483). Statistical significance was considered to be P<0.05. Statistical package SPSS for
Windows, version 17.0 (SPSS Inc, Chicago, III), was used for statistical analysis.

3.3 Results
During a mean follow-up of 19.2 years, 2020 men and 1807 women developed HF.
General characteristics of the study population at baseline are presented by levels of coffee
consumption in Table 7. After adjustment for age and study year, coffee consumption had a
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Table 7. Baseline characteristics among men and women by volume of coffee consumption*
Daily coffee consumption, cups

P value

0

1-2

3-4

5-6

7-9

≥10

1887

3510

7042

8916

4127

3355

Age, y

43.6(0.3)

45.7(0.2)

45.8(0.1)

45.6(0.1)

44.3(0.2)

43.0(0.2)

<0.001

BMI, kg/m2

26.0(0.1)

26.3(0.1)

26.4(0.0)

26.5(0.0)

26.4(0.0)

26.6(0.1)

<0.001

Systolic blood pressure, mmHg

141(0.1)

143(0.3)

143(0.2)

142(0.2)

142(0.3)

142(0.3)

<0.001

Diastolic blood pressure, mmHg

86(0.3)

88(0.2)

87(0.1)

87(0.1)

86(0.2)

86(0.2)

<0.001

Total cholesterol, mg/dL

224(1.0)

229(0.7)

234(0.5)

238(0.5)

241(0.7)

243 (0.8)

<0.001

Education, y

10.2(0.1)

10.3(0.1)

10.0(0.0)

9.3 (0.0)

9.0(0.1)

8.8(0.1)

<0.001

Low physical activity, %

8.9

8.1

7.2

7.6

7.3

10.0

<0.001

Tea drinker, %

65.0

63.3

41.1

24.7

14.4

11.5

<0.001

Alcohol drinker, %

55.2

72.5

69.1

66.6

63.9

60.0

<0.001

Characteristics

for trend

Men
Participants, n
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Table 7 continued
Current smoker, %

22.7

29.3

33.7

42.8

50.4

64.6

<0.001

History of myocardial infarction, %

3.2

3.7

4.2

3.7

2.4

2.8

<0.001

History of diabetes, %

2.1

3.0

2.3

2.3

2.4

2.6

0.176

History of valvular heart disease, %

0.2

0.2

0.2

0.1

0.0

0.1

0.341

2015

4348

9777

9775

3287

1451

Age, y

40.0(0.3)

44.5(0.2)

45.8(0.1)

45.9(0.1)

44.3(0.2)

43.2(0.3)

<0.001

BMI, kg/m2

25.8(0.1)

25.7(0.1)

25.9(0.0)

26.3(0.0)

26.6 (0.1)

26.9(0.1)

<0.001

Systolic blood pressure, mmHg

139(0.4)

138(0.3)

138(0.2)

139(0.2)

138(0.3)

138 (0.5)

0.200

Diastolic blood pressure, mmHg

82(0.2)

83(0.2)

83(0.1)

83 (0.1)

83(0.2)

82(0.3)

<0.001

Total cholesterol, mg/dL

229(1.0)

228(0.7)

230(0.4)

233(0.4)

235 (0.8)

233(1.1)

<0.001

Education, y

10.5(0.1)

10.7(0.0)

10.3(0.0)

9.7(0.0)

9.3(0.1)

9.2(0.1)

<0.001

13.6

10.8

9.1

8.5

9.1

11.8

<0.001

Women
Participants, n

Low physical activity, %
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Table 7 continued
Tea drinker, %

69.0

65.8

43.8

25.4

14.7

12.5

<0.001

Alcohol drinker, %

29.6

43.0

41.0

37.8

36.6

36.8

<0.001

Current smoker, %

5.3

10.7

15.2

20.9

25.1

43.4

<0.001

History of myocardial infarction, %

1.5

1.4

0.9

0.8

0.6

1.1

0.001

History of diabetes, %

2.3

2.2

1.8

1.7

2.1

1.7

0.267

History of valvular heart disease, %

0.1

0.1

0.1

0.1

0.0

0.0

0.377

*All data, except age, adjusted for age and study year.
*Values represent mean (SE) or percentage.
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Table 8. Hazard ratio for heart failure by categories of coffee consumption
Daily coffee consumption, cups

P value

0

1-2

3-4

5-6

7-9

≥10

No. of cases

113

185

438

691

338

255

Person-years

32097

61573

126507

169558

82149

61938

Adjustment for age and study year

1.00

0.97 (0.76-1.24)

1.05 (0.85-1.30)

1.12 (0.91-1.38)

1.17 (0.94-1.47)

1.41 (1.13-1.78)

0.001

Multivariate adjustment*

1.00

0.91 (0.71-1.16)

0.88 (0.70-1.10)

0.91 (0.73-1.13)

0.96 (0.76-1.22)

1.02 (0.80-1.30)

0.485

No. of cases

84

149

514

681

257

122

Person-years

31833

74339

184786

212511

75168

29983

Adjustment for age and study year

1.00

0.73 (0.56-0.97)

0.76 (0.60-0.97)

0.74 (0.58-0.93)

0.88 (0.68-1.14)

1.12 (0.85-1.50)

<0.001

Multivariate adjustment*

1.00

0.73 (0.56-0.97)

0.77 (0.60-0.98)

0.68 (0.53-0.88)

0.80 (0.61-1.04)

0.88 (0.65-1.19)

0.007

for trend

Men

Women

*Adjusted for age, study year, education, cigarette smoking (never, past, and current smoking of 1-19 or ≥20 cigarettes/d), alcohol consumption
(yes and no), physical activity, BMI, systolic blood pressure, total cholesterol, history of myocardial infarction, diabetes, valvular heart disease,
and tea consumption.
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Table 9. Hazard ratio for heart failure by categories of tea consumption
Daily tea consumption, cups

P value for trend

0

1-2

≥3

No. of participants

19,312

6,888

2,637

No. of cases

1, 472

379

169

Person-years

361,420

122,015

50,388

Adjustment for age and study year

1.00

0.85 (0.76-0.95)

0.80 (0.68-0.95)

0.002

Multivariate adjustment*

1.00

0.96 (0.85-1.08)

0.96 (0.81-1.15)

0.741

No. of participants

18,969

9,394

2,290

No. of cases

1, 268

413

126

Person-years

389,614

175,855

43,152

Adjustment for age and study year

1.00

0.84 (0.76-0.94)

0.99 (0.83-1.19)

0.011

Multivariate adjustment*

1.00

0.90 (0.80-1.01)

0.98 (0.81-1.20)

0.208

Men

Women

* Adjusted for age, study year, education, cigarette smoking (never, past, and current smoking of 1-19 or ≥20 cigarettes/d), alcohol consumption
(yes and no), physical activity, BMI, systolic blood pressure, total cholesterol, history of myocardial infarction, diabetes, valvular heart disease,
and coffee consumption.
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direct association with BMI level and current smoking, and an inverse association with
education level and tea consumption.
In age and study year-adjusted analysis, we found a positive association between coffee
consumption and the risk of HF for men (Table 8); however, when we further adjusted for
other risk factors (BMI, smoking, education, alcohol consumption, tea consumption, physical
activity, systolic blood pressure, history of myocardial infarction, history of valvular hear
disease, history of diabetes, and total cholesterol), the positive association in men
disappeared, which suggests that the age and study year-adjusted results were strongly
confounded by other risk factors for HF. In women, a significant inverse association between
low-to-moderate coffee consumption (1-6 cups/day) and the risk of HF was found in age and
study year-adjusted analysis. Additional adjustment for other risk factors did not appreciably
alter the results. The pooled multivariable-adjusted hazard ratios (HRs) across categories of
coffee consumption were 1.00, 0.83 (95% confidence interval [CI] 0.69-1.00), 0.85 (95% CI
0.72-1.00), 0.81 (95% CI 0.69-0.96), 0.90 (95% CI 0.76-1.08), and 0.98 (95% CI 0.81-1.18)
(Ptrend=0.009).
In age and study year-adjusted analysis, we found a negative association between tea
consumption and the risk of HF for men and women (Ptrend=0.002 for men and Ptrend=0.011
for women) (Table 9). After further adjustment for other risk factors, these inverse
associations were no longer significant (all Ptrend>0.2).
Stratification by age, smoking status, alcohol consumption, history of type 2 diabetes
mellitus, and BMI gave similar results.
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Exclusion of the participants who died during the first two years of follow-up did not
appreciably change the results above.

3.4 Discussion
In this large population-based prospective study, we did not find any detrimental effect
of coffee consumption on the risk of HF in either men or women. Actually, in women
low-to-moderate amount of coffee drinking was associated with a reduced risk of HF.
To the best of our knowledge, only two studies have assessed the association between
coffee consumption and the risk of HF, and both studies included Swedish men.(Ahmed et
al., 2009; Wilhelmsen et al., 2001) The results of the present study support the findings of
prior work that coffee consumption is not significantly associated with the risk of HF in men.
(Ahmed et al., 2009) Moreover, for the first time, the present study also included women and

observed a decreased risk of HF in women with low-to-moderate coffee consumption (1-6
cups daily). According to international statistics, the Finnish population has the highest per
capita coffee consumption in the world, at 11.4 kg/year.(World Resources Institute) Research
into the potential health effects of coffee in this population is therefore of particular interest.
Although the mechanism behind the association between coffee consumption and the
risk of HF among women is incompletely understood, several putative mechanisms have
been proposed. Because HF and CHD share risk factors such as: hypertension, diabetes,
obesity, and smoking, CHD is regarded as a more common etiology in HF than ever
before.(Fox KF, 1998; Wilhelmsen et al., 2001) In our study population, it has been
previously shown that coffee drinking was associated with decreased CHD
mortality(Kleemola et al., 2000) and the incidence of type 2 diabetes,(Tuomilehto et al.,
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2004) whereas the lowest incidence of hypertension was found in people who did not drink
coffee but no gradient in hypertension incidence with increasing coffee drinking was
seen.(Hu et al., 2007b) Also, Wu et al.(Wu et al., 2009) reported that their meta-analysis of
21 prospective cohort studies on the association between coffee consumption and the risk of
CHD did not support the hypothesis that coffee consumption increases the long-term risk of
CHD, and habitual moderate coffee drinking was associated with a lower risk of CHD in
women.(Wu et al., 2009) Their findings on the relationship between coffee consumption and
the risk of CHD are similar with our findings about the association between coffee
consumption and the risk of HF. Therefore, the effect of coffee consumption on HF may be
partly mediated by its effect on other risk factors for CHD. In our study, the adjustment for
the history of myocardial infarction and other CHD risk factors attenuated the association
between coffee consumption and HF risk, and the association still remained significant
among women but not among men.
The reason for the gender difference we have observed in the association between coffee
consumption and HF risks is unclear. This finding is however in keeping with the finding of
the observation regarding CHD mortality based on these same data: inverse association in
women while no association in men.(Kleemola et al., 2000) Many epidemiologic studies
have demonstrated that it is more likely for smokers than non-smokers to have more
unhealthy lifestyle habits (e.g., physical inactivity, alcohol abuse).(Aasland and Nylenna,
1997) In the present study, coffee consumption was directly associated with smoking, and
the prevalence of smoking was much higher among men than women. Although smoking
was adjusted in our study, not all smoking-related unhealthy lifestyle habits were controlled.
55

Therefore, one explanation involved is that the difference in the prevalence of smoking
between men and women and smoking related unhealthy lifestyle habits may be partially
responsible for the observed gender difference in the association between coffee
consumption and HF risk.(Wu et al., 2009)
There are mainly three categories of functional compounds in coffee: caffeine,
antioxidants, and trace elements. Caffeine, a major component of coffee, prevents
adenosine’s negative inotropic effect as an adenosine-receptor antagonist(Van Soeren and
Graham, 1998) and increases the sensitivity of the myofilaments to calcium.(Hess and Wier,
1984) Also, caffeine decreases insulin sensitivity(Keijzers et al., 2002) and increases serum
homocysteine levels(Verhoef et al., 2002) and blood pressure.(Noordzij et al., 2005) In
addition, caffeine stimulates free fatty acid release from peripheral tissues.(Ryu et al., 2001)
On the other hand, antioxidants, obtained from coffee, like chlorogenic acid, phenolic
compounds, flavonoids, melanoidins, and various lipid-soluble compounds such as furans,
pyrroles, and maltol have beneficial antioxidant effects and might improve insulin
sensitivity.(Arnlov et al., 2004) Trace elements in coffee such as potassium, niacin, and
magnesium have beneficial effects on glucose and insulin metabolism,(Natella et al., 2002)
improve insulin sensitivity,(Arnlov et al., 2004) decrease low-grade
inflammation,(Lopez-Garcia et al., 2006) and lower diabetes risk.(van Dam and Hu, 2005) In
our prior work, we observed an inverse and graded association between coffee consumption
and type 2 diabetes,(Tuomilehto et al., 2004) which is recognized as one of the risk factors of
HF.
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There are several strengths and limitations in our study. First, a large number of both
men and women from a homogeneous population participated in the study. Second, the mean
follow-up was sufficiently long to ascertain a large number of HF endpoint events. We also
carried out additional analyses excluding the subjects who died during the first two years of
follow-up to avoid a potential bias due to a possible change in coffee consumption with
severe disease. A limitation of our study was that we used self-report data on coffee intake
only at baseline. However, the misclassification of exposure during the follow-up is most
probably not systematically related to the outcome. Second, we did not assess the effect of
caffeine on the risk of coffee consumption since we did not have available information about
other main sources of caffeine, i.e. the consumption of cola beverage and chocolate. Third,
even though our analyses were adjusted for physical activity, smoking, tea, and alcohol
intake, residual confounding due to the measurement error in the assessment of confounding
factors, unmeasured factors such as diet, cannot be excluded. In general, the associations
between coffee consumption and HF risk were not influenced substantially or systematically.
Finally, ascertainment of HF status was based on the National Hospital Discharge Registry,
the National Social Insurance Institution’s Register on special reimbursement for HF drugs,
and Causes of Death Register. This diagnosis method has been used in other Scandinavian
countries, such as Finland and Sweden.(Ingelsson et al., 2005a; Wang et al.) The accuracy of
the HF cases in the Swedish hospital discharge is found to be over 80% based on the ESC
definition.(Ingelsson et al., 2005a) Although accuracy of clinical HF diagnosis in our cohort
is likely to be high, some diagnostic errors are inevitable. However, the misdiagnosis is most

57

likely to be independent of the exposure status and therefore tends to attenuate the
underlying associations rather than cause spurious associations.
In conclusion, our study confirms that coffee consumption does not increase the risk of
HF in Finnish men and women who have the highest consumption of coffee in the world. In
women, we observed an inverse association between low-to-moderate coffee consumption
and the risk of HF.
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CHAPTER 4. LIFESTYLE FACTORS IN RELATION TO HEART FAILURE
AMONG FINNISH MEN AND WOMEN4
4.1. Introduction
Heart failure (HF) poses a great threat to people around the world with its high prevalence,
poor clinical outcomes, and large health-care costs.(Krum and Abraham, 2009; Sharp and
Doughty, 1998) Except for the medical treatments for the cardiovascular risk factors of HF,
modifiable lifestyle factors can also affect the development of HF. Compared with medical
intervention, the prevention of HF through lifestyle approaches is free of side effect.
Modifiable lifestyle factors like smoking,(Djousse et al., 2009; Eriksson et al., 1989a; He et al.,
2001; Hoffman et al., 1994; Wilhelmsen et al., 2001) physical activity,(Djousse et al., 2009;
Hu et al., 2010b; Kenchaiah et al., 2009; Wang et al., 2010b) adiposity,(Djousse et al., 2009;
Hu et al., 2010b; Kenchaiah et al., 2002; Kenchaiah et al., 2009; Levitan et al., 2009a) alcohol
consumption,(Abramson et al., 2001; Bryson et al., 2006; Djousse et al., 2009; Djousse and
Gaziano, 2007a; Walsh et al., 2002) and dietary intake,(Djousse et al., 2009; Wang et al.,
2011b) have been shown to influence the risk of HF in several studies. In the only
epidemiological investigation related to the joint effect of these modifiable lifestyle factors on
HF risk,(Djousse et al., 2009) engaging in healthy lifestyle factors was associated with the
remaining lifetime risk of HF in men. However, it is unclear if this observed finding is
generalizable to other populations and to both sexes. In order to gain a more comprehensive
understanding of the effect of engaging in lifestyle factors on HF risk, we aim to examine the

4

This chapter originally appeared as Yujie Wang, Jaakko Tuomilehto, Pekka Jousilahti, Riitta Antikainen, Markku
Mähönen, Peter T. Katzmarzyk, and Gang Hu. Lifestyle factors in relation to heart failure among Finnish men and women.
Circulation: heart failure, 4(5), 607-612, 2011. Reprinted by permission of Wolters Kluwer Health.
http://circheartfailure.ahajournals.org/content/4/5/607
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single and combined effects of smoking, body mass index (BMI), physical activity, and
vegetable intake on HF risk in a large prospective cohort of Finnish men and women.
4.2 Methods
Subjects
Five independent cross-sectional population-based health examination surveys (FINRISK)
were carried out in six geographic areas of Finland in 1982, 1987, 1992, 1997 and
2002.(Vartiainen et al.) The original random sample was stratified by area, gender and 10-year
age group according to the World Health Organization (WHO) MONICA (MONItoring trends
and determinants of CArdiovascular disease) protocol.(Pajak et al., 1988) The participation
rate varied by year from 65% to 88%.(Vartiainen et al.) The subjects included in the five
surveys were 25 to 64 years of age, and the 1997 and 2002 surveys also included subjects aged
65 to 74 years. Subjects who participated in more than one survey were included only in the
first survey cohort. The total sample size of the five surveys was 38,737. The final sample
comprised 18,346 men and 19,729 women after excluding the participants with a history of HF
(n=457) at baseline, and the participants with incomplete data on any variables required for
this analysis (n=205). The participants gave an informed consent (verbal from 1982 to 1992
and written in 1997 and 2002). These surveys were conducted according to the ethical rules of
the National Public Health Institute, and the investigations were performed in accordance with
the Declaration of Helsinki.
Baseline measurements
A self-administered questionnaire was mailed to the participants to be completed at home
and returned to the survey site. The questionnaire included questions on medical history,
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socioeconomic factors, physical activity, smoking habits, dietary intake, and alcohol
consumption. Education level, measured as the total number of school years, was divided into
birth cohort-specific tertiles. Data on the history of myocardial infarction or diabetes mellitus
at baseline were obtained from the questionnaire and collected by hospital discharge diagnosis
or drug register. Data on the use of antihypertensive agents at baseline were obtained from the
questionnaire and drug register. Data on the history of valvular heart disease at baseline were
collected by hospital discharge register.(Hu et al., 2010b; Hu et al., 2003; Wang et al., 2010b;
Wang et al., 2011b)
A detailed description of the questions on occupational and leisure-time physical activity
has been presented elsewhere.(Hu et al., 2003; Wang et al., 2010b) Since we found that
moderate and high occupational or leisure time physical activity independently and
significantly reduces risk of HF,(Hu et al., 2010b; Wang et al., 2010b) the groups were merged
into three categories: “low” when subjects reported light levels of both occupational and
leisure time physical activity; “moderate” when subjects reported moderate or high level of
either occupational or leisure time physical activity; and “high” when subjects reported
moderate or high level of both occupational and leisure time physical activity. Participants
were classified as never, ex- and current-smokers based on their responses to the questionnaire.
Alcohol consumption was categorized into four groups: none, 0.1-35, 35.1-70, and >70 g per
week. The frequency of consumption of vegetables and fruits over the last week (<1
time/week, 1-2 times/week, 3-6 times/week, ≥7 times/week) were also inquired.(Hu et al.,
2007d)
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At the survey site, specially trained research nurses measured participants’ height and
weight by using the standardized WHO MONICA protocol.(Pajak et al., 1988) Height and
weight were measured without shoes and with light clothing. The measurements of height
were rounded to the nearest centimeter and weight to nearest 100 grams.(Pajak et al., 1988)
BMI was calculated as weight in kilograms divided by the square of height in meters. Blood
pressure was measured from the right arm after five minutes of sitting using a mercury
sphygmomanometer in each survey. After blood pressure measurement, a venous blood
specimen was taken. Total cholesterol was determined by an enzymatic method (CHOD-PAP,
Boehringer MANNHEIM, Mannheim, Germany). All samples were analyzed in the same
central laboratory at the National Public Health Institute.
Prospective follow-up
Follow-up information was from the Finnish Hospital Discharge Register and the
National Social Insurance Institution’s Register on special reimbursement for HF drugs for
non-fatal outcomes and the Finnish Causes of Death Register for fatal outcomes by record
linkage using the personal identification numbers assigned to every citizen of Finland. The
International Classification of Diseases (ICD) codes 427.00 and 427.10 (ICD-8), 428, 4029B
(hypertensive heart disease with HF) and 4148A-X (ischemic HF with chronic coronary heart
disease [CHD]) (ICD-9), and I 50, I11.0 (hypertensive heart disease with HF), I13.0 and I13.2
(hypertensive heart and renal disease with HF) (ICD-10) were used to identify HF cases in the
above-mentioned national databases. A HF diagnosis was made by the treating physicians,
based on a clinical assessment and examinations as considered relevant by the clinician in
charge of treatment. Follow-up of each cohort member continued until the date of the
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diagnosis of HF from the Hospital Discharge Register, Causes of death register or from the
National Social Insurance Institution’s Drug reimbursement Register or death resulting from
causes other than HF, or December 31, 2007. This method to ascertain HF cases in prospective
epidemiological studies has been used in Scandinavian countries, such as Sweden and
Finland.(Ingelsson et al., 2005a; Levitan et al., 2009a; Wang et al., 2010a) A study from
Sweden found the positive predictive value of HF diagnosis to be 82% (false positive rate
18%).(Ingelsson et al., 2005a) Another study from Finland also found the specificity of the
HF diagnoses to be acceptable for the epidemiological study.(Wang et al., 2010a)
Statistical analyses
Cox proportional hazards regression was used to calculate the hazard ratio (HR) and 95%
confidence intervals (CIs) for categories of each of the 6 modifiable lifestyle factor (smoking
[never, ever, and current], BMI [normal weight:<25 kg/m2, overweight: 25-29.9 kg/m2, and
obese: ≥30 kg/m2], physical activity [low, moderate, and high], vegetable consumption [<1,
1-2, 3-6, and ≥7 times per week], fruit consumption [<1, 1-2, 3-6, and ≥7 times per week], and
alcohol consumption [none, 0.1-35, 35.1-70, and >70 g per week]).
Next, each lifestyle factor was dichotomized as unhealthy vs healthy: smoking (current vs
never or ever), BMI (≥25 vs <25 kg/m2), physical activity (low vs moderate or high), and
vegetable consumption (≤2 vs ≥3 times per week). Fruit consumption and alcohol
consumption were dropped out of the analyses because no significant associations with HF
risk were found. Given that healthy lifestyle factors were defined as never or ever smoking,
BMI <25 kg/m2, moderate or high levels of physical activity, and consumption of vegetable ≥3
times per week, each person could have a minimum of 0 and maximum of 4 healthy lifestyle
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factors. Differences in the general characteristics of study subjects who had 0, 1, 2, 3 or 4
healthy lifestyle factors were tested using General Linear Models after adjustment for age and
study year. The number of healthy lifestyle factors was included in the Cox proportional
hazards regression models as dummy and categorical variables, and the significance of the
trend over different categories was tested in the same models by giving an ordinal numeric
value for each dummy variable. The proportional hazards assumption in the Cox model was
assessed with graphical methods, and with models including time-by-covariate
interactions.(Cox, 1972) In general, all proportionality assumptions were appropriate.
All the above analyses were first carried out adjusting for age and study year, and further
for education, systolic blood pressure, total cholesterol, and histories of myocardial
infarction, valvular heart disease, diabetes, and using antihypertensive drugs. To avoid a
potential bias due to severe disease at baseline, additional analyses were carried out excluding
the subjects who died during the first two years of follow-up (n=290). Statistical significance
was considered to be P<0.05. All the above statistical analyses were performed with PASW
for Windows, version 18.0 (SPSS Inc, Chicago, III).
To estimate the proportion of new HF cases occurring in this population that
hypothetically could have been prevented if all subjects had been in the healthy lifestyle group,
while the distribution of other modifiable and non-modifiable risk factors is unchanged, the
partial population attributable risk percent (PAR%) (Spiegelman et al., 2007) and 95% CI
were calculated by using SAS for Windows, version 9.12 (SAS Institute, Cary, NC).
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4.3 Results
During a median follow-up of 14.1 years (interquartile range 5.9-20.9 years), 638 men and
445 women developed HF. General characteristics of the study population at baseline are
presented by the number of healthy lifestyle factors in Table 10.
Except for fruit consumption and alcohol consumption, the other individual components
of the lifestyle factors were independently and significantly associated with the risk of HF
when they were simultaneously entered into the multivariable model (Table 11). The most
important risk factor for HF was smoking status; the HR of HF was 1.86 (95% CI 1.51-2.30)
for men and 2.09 (95% CI 1.59-2.74) for women who were current smoker, as compared with
subjects who never smoked. Overweight or obesity was also associated with a significantly
increased HF risk, while engagement in moderate-to-high levels of physical activity, the
consumption of vegetable more than three times per week were associated with a significantly
decreased HF risk.
In both age and study year-adjusted analysis and the multivariable-adjusted (age, study
year, education, systolic blood pressure, total cholesterol, and histories of myocardial
infarction, valvular heart disease, diabetes, and using antihypertensive drugs) analysis, a
dose-response relationship between the combinations of the 4 healthy lifestyle factors
(physical activity, smoking, BMI, and vegetable consumption) and the hazard ratios of HF was
observed (Table 12). The partial PAR% associated with engaging in any 3 or 4 of the
healthy lifestyle indicators were 45.6% (95% CI 36.5% - 53.8%) and 53.6% (95% CI 31.3% 70.2%), respectively, suggesting that 45.6% or 54.1% of new HF cases occurring in this
population could have been prevented if all subjects had any 3 or 4 of the healthy lifestyle
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Table 10. General characteristics of study at baseline*
No. of healthy lifestyle factors†
0

1

2

3

4

P for trend

No. of subjects

1,473

5,267

6,633

3,969

1,004

Age at baseline (yrs)

47.5 (11.7)

48.7 (12.5)

47.2 (12.5)

44.3 (11.8)

41.4 (10.6)

<0.001

Body mass index (kg/m2)

29.1 (3.4)

27.8 (4.0)

26.9 (3.8)

25.3 (3.4)

23.2 (1.4)

<0.001

Current smoker (%)

100

53.8

28.3

11.5

0.0

<0.001

Moderate or high physical activity (%)

0.0

16.7

41.8

70.2

100

<0.001

Vegetable consumption ≥3 time/week (%)

0.0

18.5

55.8

82.8

100

<0.001

Alcohol consumption (g/week)

107 (154)

89 (146)

77 (113)

67 (92)

56 (70)

<0.001

Diastolic blood pressure (mm Hg)

87 (12)

86 (12)

85 (12)

83 (11)

80 (11)

<0.001

Systolic blood pressure (mm Hg)

145 (19)

143 (19)

141 (19)

138 (18)

135 (17)

<0.001

Serum cholesterol (mmol/l)

6.13 (1.17)

6.00 (1.18)

5.81 (1.15)

5.66 (1.13)

5.46 (0.99)

<0.001

Men
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Table 10 continued
Education (yrs)

9.3 (3.3)

9.7 (3.8)

10.7 (4.0)

11.5 (4.0)

11.8 (3.7)

<0.001

History of myocardial infarction (%)

5.6

4.8

3.8

2.9

3.1

<0.001

History of valvular heart disease (%)

0.1

0.2

0.2

0.2

0.2

0.767

History of diabetes (%)

3.1

3.2

2.8

2.5

1.9

0.124

History of using anti-hypertensive drugs (%)

12.8

13.7

12.8

8.5

4.1

<0.001

No. of subjects

500

3,573

7,189

6,227

2,240

Age at baseline (yrs)

44.9 (12.0)

48.8 (12.6)

47.8 (12.6)

44.0 (11.4)

41.0 (9.8)

<0.001

Body mass index (kg/m2)

29.9 (4.3)

28.9 (5.2)

27.1 (4.9)

24.5 (4.0)

22.4 (1.7)

<0.001

Current smoker (%)

100.0

41.5

21.5

8.9

0

<0.001

Moderate or high physical activity (%)

0.0

5.3

19.9

52.7

100.0

<0.001

Vegetable consumption ≥3 time/week (%)

0.0

19.5

67.8

89.0

100.0

<0.001

Alcohol consumption (g)

40 (65)

25 (51)

26 (50)

25 (41)

23 (36)

<0.001

Women
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Table 10 continued
Diastolic blood pressure (mm Hg)

83 (12)

82 (11)

81 (11)

79 (11)

71 (10)

<0.001

Systolic blood pressure (mm Hg)

137 (20)

140 (22)

137 (21)

132 (20)

128 (17)

<0.001

Serum cholesterol (mmol/l)

5.94 (1.25)

5.99 (1.26)

5.81 (1.22)

5.56 (1.13)

5.35 (1.03)

<0.001

Education (yrs)

9.8 (3.1)

9.5 (3.6)

10.7 (3.9)

12.0 (3.9)

12.7 (3.6)

<0.001

History of myocardial infarction (%)

1.9

2.0

1.0

0.6

0.6

<0.001

History of valvular heart disease (%)

0.2

0.1

0.1

0.1

0.1

0.872

History of diabetes (%)

2.5

2.7

2.6

1.6

1.1

<0.001

History of using anti-hypertensive drugs (%)

12.0

15.6

14.1

7.6

3.2

<0.001

*Values are given as mean (SD) when appropriate.
†Four modifiable lifestyle factors included smoking, body mass index, physical activity, and vegetable consumption.
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Table 11. Hazard ratios of heart failure according to lifestyle factors
Men

Lifestyle factors

No. of

Person-y

Multivariable adjustment

cases

rs

HR (95% CI)* †

Physical activity

P for

Women

P for

trend

No. of

Person-

Multivariable adjustment

cases

yrs

HR (95% CI)* †

0.006

0.009

Light

128

27,863

1.00

129

44,435

1.00

Moderate

334

118,082

0.79 (0.64-0.97)

229

138,989

0.87 (0.70-1.08)

High

176

115,186

0.67 (0.53-0.86)

87

109,288

0.64 (0.48-0.86)

Smoking status

trend

<0.001

<0.001

Never

153

98,111

1.00

347

201,982

1.00

Ever

213

67,484

1.06 (0.86-1.31)

25

32,189

1.02 (0.68-1.55)

Current

272

95,537

1.86 (1.51-2.30)

73

58,542

2.09 (1.59-2.74)

272

94,275

1.00

346

170,956

1.00

Alcohol consumption (g/week)
0

0.225
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0.899

Table 11 continued
0.1-35

75

34,306

0.91 (0.70-1.18)

54

54,170

0.90 (0.67-1.21)

35.1-70

92

40,378

1.00 (0.79-1.27)

30

38,268

1.01 (0.68-1.50)

>70

199

92,173

1.17 (0.96-1.42)

15

29,318

0.92 (0.53-1.57)

Body mass index (kg/m2)

<0.001

<0.001

<25

142

95,701

1.00

97

145,836

1.00

25-29.9

293

122,376

1.15 (0.93-1.41)

155

95,847

1.21 (0.93-1.57)

≥30

203

43,055

1.75 (1.40-2.20)

193

51,030

2.06 (1.59-2.67)

Fruit consumption (time/week)

0.471

0.799

<1

109

36,062

1.00

48

18,735

1.00

1-2

261

99,472

1.14 (0.91-1.44)

133

71,441

0.89 (0.63-1.24)

3-6

153

74,523

1.00 (0.77-1.30)

129

89,447

0.92 (0.65-1.29)

≥7

115

51,074

1.11 (0.83-1.47)

135

113,090

0.85 (0.60-1.20)

Vegetable consumption (time/week)

0.047

70

0.153

Table 11 continued
<1

162

41,126

1.00

74

20,714

1.00

1-2

258

95,067

0.88 (0.72-1.08)

162

80,296

0.89 (0.67-1.18)

148

81,316

0.74 (0.58-0.94)

123

109,376

0.73 (0.54-0.99)

70

43,623

0.70 (0.51-0.96)

86

82,328

0.93 (0.60-1.31)

3-6
≥7

*HR = hazard ratio; CI = confidence interval.
†Adjusted for age, study year, smoking, vegetable consumption, fruit consumption, education, alcohol consumption, history of myocardial
infarction, history of valvular heart disease, history of diabetes, history of using anti-hypertensive drugs, BMI, systolic blood pressure, and total
cholesterol, other than the variable in the analytic model.
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Table 12. Hazard ratios of heart failure according to number of healthy lifestyle factors restricted to adiposity, smoking, physical activity, and
vegetable consumption
men
No. of healthy

No. of cases

women
Person-yrs

lifestyle factors

Age and study

Multivariable

years adjusted HR

adjustment HR

(95% CI) *

(95% CI)

No. of cases
Person-yrs

†

Age and study

Multivariable

years adjusted HR

adjustment HR

(95% CI)

(95% CI) †

0

97

19,441

1.00

1.00

20

7,009

1.00

1.00

1

271

72,805

0.64 (0.50-0.80)

0.68 (0.54-0.86)

168

53,030

0.59 (0.37-0.94)

0.53 (0.33-0.85)

2

191

93,954

0.39 (0.31-0.50)

0.44 (0.35-0.57)

185

104,487

0.43(0.27-0.69)

0.42 (0.27-0.67)

3

67

59,020

0.28 (0.20-0.38)

0.33 (0.24-0.45)

61

93,757

0.24 (0.14-0.39)

0.24 (0.14-0.40)

4

12

15,912

0.25 (0.14-0.46)

0.30 (0.16-0.54)

11

34,431

0.18 (0.08-0.37)

0.19 (0.09-0.40)

<0.001

<0.001

<0.001

<0.001

P for trend

*HR = hazard ratio; CI = confidence interval.
†Adjusting for age, study year, education, history of myocardial infarction, history of valvular heart disease, history of diabetes, history of using
anti-hypertensive drugs, systolic blood pressure, and total cholesterol.
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indicators. However, since PAR% assumes the lifestyle factors are causal, it should be
interpreted with caution.
Exclusion of the participants who died during the first two years of follow-up did not
appreciably change the results above.

4.4 Discussion
In the present study, we observed that maintaining a BMI ≤25, consuming vegetable ≥3
times a week, abstaining from smoking and engaging in moderate or high level of physical
activity were individually and jointly associated with a decreased risk of HF among both men
and women. Furthermore, the dose-response relationship between the number of healthy
lifestyle factors one engaged in and HF risk suggested that the closer one was engaging in a
healthy lifestyle, the further the risk of HF was reduced.
Smoking, which was identified as the most powerful predictor of incident HF in the
current cohort, was first shown to be the major independent risk factor of HF in a study
(Eriksson et al., 1989a) conducted on 973 men born in 1913 in Gothenburg, Sweden. The
authors found that smoking at age 50 was associated with a 60% higher risk of Congestive HF
(RR, 1.6; 95%, 1.2-3.2), and this relationship was independent of hypertension and other
important risk factors of Congestive HF. The finding has been confirmed by several other
studies conducted on different population.(He et al., 2001; Hoffman et al., 1994; Wilhelmsen
et al., 2001) Based on the evidence revealing the positive association between smoking and HF,
the European Society of Cardiology, American College of Cardiology, and American Heart
Association identified smoking as one of the risk factors as well as one of the targets of

73

prevention and management of HF in their guidelines.(Dickstein et al., 2008; Hunt et al., 2005;
Schocken et al., 2008b)
The relation of physical activity(He et al., 2001; Hu et al., 2010b; Kenchaiah et al., 2009;
Wang et al., 2010b) and obesity(Bahrami et al., 2008; Chen et al., 1999; He et al., 2001; Hu et
al.; Ingelsson et al., 2005b; Ingelsson et al., 2005c; Kenchaiah et al., 2002; Kenchaiah et al.,
2009; Levitan et al., 2009a; Loehr et al., 2009) to HF has been studied extensively. The results
from these prospective studies consistently indicate that regular physical activity reduces the
risk of HF, while both general obesity and abdominal obesity increase the risk of HF.
Furthermore, research (Hu et al., 2010b; Kenchaiah et al., 2009) related to the joint effect of
obesity and physical activity on HF risk indicates that lean and active individuals had the
lowest HF risk. Therefore, preventing of HF by maintaining optimal weight and involving in
regular physical activity may be promising in reducing the public health burden of HF
worldwide.
Although dietary pattern and food choices have been associated with risk factors for HF
such as hypertension, CHD and type 2 diabetes, the role of diet on HF has not been studied
adequately to date. Djousséea al (Djousse et al., 2009; Djousse and Gaziano, 2007b) have
done extensive work to evaluate the associations between dietary factors on the risk of HF by
using the data from the Physicians’ Health Study: their studies showed that fruit and vegetable
consumption (Djousse et al., 2009) and whole-grain breakfast cereals consumption (Dhingra
et al., 2010) were associated with a reduced risk of HF. The Swedish Mammography Cohort
showed that diets consistent with the DASH diet, a diet features high intake of fruits,
vegetables, low-fat dairy products, and whole grains, were associated with a decreased risk of
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HF.(Levitan et al., 2009b) In the current study, fruit consumption was not associated with the
risk of HF which is different from the findings from the study conducted by Djousséea
al.(Djousse et al., 2009) The inconsistency might be partly explained by the different
questionnaires used to assess fruit consumption, and the differences in the dietary habits
between the Finish population and Americans. All these studies together with the current
study suggest that the prevention of HF through dietary approaches should be stressed.
The studies that have addressed alcohol consumption and the risk of HF have yielded
inconsistent results.(Abramson et al., 2001; Bryson et al., 2006; Djousse et al., 2009; Djousse
and Gaziano, 2007a; Walsh et al., 2002) Like us, Bryson et al(Bryson et al., 2006) did not find
a significant association between alcohol consumption and the risk of HF. In contrast, several
studies(Abramson et al., 2001; Bryson et al., 2006; Djousse et al., 2009; Walsh et al., 2002)
showed that moderate alcohol consumption was associated with a reduced risk of HF, whereas
alcohol abuse was associated with a higher risk of HF.(Wilhelmsen et al., 2001) The
discrepancy among these findings may be partly explained by the different assessment of
alcohol consumption, and the age and race difference between the study samples of these
studies. In order to establish the association between alcohol consumption and HF and make
appropriate recommendations to the general public especially those at high risk for HF, further
studies are needed.
To the best of our knowledge, the only study(Djousse et al., 2009) addressing the
association between the joint effect of modifiable lifestyle factors on HF risk was conducted
among male physicians who are more aware of the consequences of unhealthy lifestyle than
the general public. The results of the present study support their finding that engaging in
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healthy lifestyle factors is associated with a lower HF risk in men. Moreover, for the first time,
the present study demonstrated a similar association in women. Although each of these 4
modifiable lifestyle factors has been shown to be independently associated with the risk of HF
in various studies, the general public does not have enough awareness of these associations,
and the prevalence of unhealthy lifestyle continues to be high. Large social and
community-based lifestyle intervention may help to prevent and manage HF.
There are several strengths and limitations in our study. First, a major strength of the study
is the large number of both men and women from a homogeneous population who participated
in the study. Second, the follow-up time was sufficiently long to ascertain a large number of
HF endpoint events. Finally, we also carried out additional analyses excluding the subjects
who died during the first two years of follow-up to avoid a potential bias due to a severe
disease at baseline. A limitation of our study is that information on self-reported physical
activity, smoking habits, vegetable and alcohol consumptions was recorded only once at
baseline. We have no data on possible changes in the lifestyle factors during the follow-up.
However, the misclassification of the levels of these lifestyle factors during the follow-up is
most probably not systematically related to the outcome, but may weaken the observed
association. Ascertainment of HF status was based on the National Hospital Discharge
Registry, the National Social Insurance Institution’s Register on special reimbursement for HF
drugs, and Causes of Death Register. These data are primarily collected for administrative
purposes and not for a scientific study. There are guidelines for assigning diagnoses in these
register and established quality control procedures, but the diagnoses may vary over time and
between the hospitals. This method for ascertaining the HF outcome has, however, been
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successfully used in prior studies in Scandinavian countries, such as Finland and Swede.(Hu et
al., 2010b; Ingelsson et al., 2005a; Levitan et al., 2009a; Wang et al., 2010a; Wang et al.,
2010b; Wang et al., 2011b) Also, we cannot completely either exclude the effects of residual
confounding due to measurement error in the assessment of confounding factors, or some
unmeasured dietary factors. An additional limitation is the use of the healthy lifestyle point
system. Each healthy lifestyle factor was weighted the same which implies that each is
equally important, though the results indicated that smoking was the strongest risk factor for
HF. This may lead to heterogeneous people being in the same category.
In conclusion, there was a graded inverse association between the number of healthy
lifestyle factors and the risk of HF in Finnish men and women. Therefore, in order to reduce
the incidence of HF, more efforts should be put into promoting healthy lifestyles and their
associated health benefits.
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CHAPTER 5. HEALTHY LIFESTYLE STATUS, ANTIHYPERTENSIVE
TREATMENT AND THE RISK OF HEART FALIURE AMONG FINNISH MEN AND
WOMEN5
5.1 Introduction
Heart failure (HF), which lead to 3,434,000 clinical visits in 2007 in the U.S,(Schappert
and Rechtsteiner, 2011) has become a major health problem. According to the American
Heart Association (AHA),(Roger et al., 2011) 1 in 9 death certificates (277,193 deaths) in the
U.S. included heart failure as a contributing cause of death in 2007.
Hypertension is one of the major risk factors of HF: 75% of HF cases have antecedent
hypertension.(Lloyd-Jones et al., 2002) However, there is little information on the risk of HF
in treated hypertensive people, controlled or uncontrolled for their blood pressure compared
with normotensive individuals followed over a long period. Also, data from our recent
publication(Wang et al., 2011a) demonstrated a graded inverse association between number of
healthy lifestyle traits (maintaining a body mass index [BMI] ≤25, consuming vegetables ≥3
times a week, abstaining from smoking and engaging in moderate or high level of physical
activity) and the risk of HF in the Finnish general population.
Ideal cardiovascular health is now defined by the presence of the traditional health
factors (untreated total cholesterol <200 mg/dL, untreated blood pressure <120/<80 mm Hg,
and fasting blood glucose <100 mg/dL) as well as ideal health behavioral factors
(nonsmoking, BMI <25 kg/m2, physical activity at goal levels, and pursuit of a diet consistent
with current guideline recommendations) according to a recent special report of the

5
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AHA.(Lloyd-Jones et al., 2010) One study has demonstrated that a healthy lifestyle
significantly decreases stroke risk in different strata of hypertension status and
antihypertensive drug treatments.(Zhang et al., 2012) However, based on the available
evidence, it is unclear that which is more effective in preventing HF in hypertensive people:
lifestyle intervention or antihypertensive drug treatment. Therefore, this study aimed to
investigate 1) whether there are differences in HF risk among hypertensive men and women
using antihypertensive drug treatment at baseline versus those engaging in a healthy lifestyle
at baseline, and 2) whether there are differences in HF risk among hypertensive men and
women by awareness, treatment and blood pressure control status at baseline.
5.2 Methods
Participants
Five independent cross-sectional population-based health examination surveys (the
National FINRISK Study) were carried out in five geographic areas of Finland in 1982, 1987,
1992, 1997 and 2002.(Vartiainen et al.) The original random sample was stratified by area,
gender and 10-year age group according to the World Health Organization (WHO) MONICA
(MONItoring trends and determinants of CArdiovascular disease) protocol.(Pajak et al., 1988)
The participation rate varied by year from 65% to 88%.(Vartiainen et al.) The subjects
included in the five surveys were 25 to 64 years of age, and the 1997 and 2002 surveys also
included subjects aged 65 to 74 years. Subjects who participated in more than one survey were
included only in the first survey cohort. The total sample size of the five surveys was 38,737.
The final sample comprised 18,346 men and 19,729 women after excluding the participants
with a history of HF (n=457) at baseline, and the participants with incomplete data on any
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variables required for this analysis (n=205). The participants provided informed consent
(verbal from 1982 to 1992 and written in 1997 and 2002). These surveys were conducted
according to the ethical rules of the National Public Health Institute, and the investigations
were performed in accordance with the Declaration of Helsinki.
Baseline measurements
A self-administered questionnaire was mailed to the participants to be completed at home
and returned to the survey site. The questionnaire included questions on medical history,
socioeconomic factors, physical activity, smoking habits, dietary intake, and alcohol
consumption. Education level, measured as the total number of school years, was divided into
birth cohort-specific tertiles. Data on the history of myocardial infarction or diabetes mellitus
at baseline were obtained from the questionnaire and collected by hospital discharge diagnosis
or drug register. Data on the use of antihypertensive agents at baseline were obtained from the
questionnaire and drug register. Data on the history of valvular heart disease at baseline were
collected by hospital discharge register.(Hu et al., 2010b; Hu et al., 2003; Wang et al., 2010b,
2011a; Wang et al., 2011b) A detailed description of the questions on lifestyle factors
including physical activity, smoking, and vegetable consumption has been presented
elsewhere.(Hu et al., 2003; Wang et al., 2010b, 2011a) Alcohol consumption was categorized
into four groups: none, 0.1-35, 35.1-70, and >70 g per week.
At the survey site, specially trained research nurses measured participants’ height and
weight by using the standardized WHO MONICA protocol.(Pajak et al., 1988) Height and
weight were measured without shoes and with light clothing. The measurements of height
were rounded to the nearest centimeter and weight to nearest 100 grams.(Pajak et al., 1988)
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BMI was calculated as weight in kilograms divided by the square of height in meters. Blood
pressure was measured twice from the right arm after five minutes of sitting using a mercury
sphygmomanometer, and the mean of these two blood pressures was used in the analyses. A
person was considered to have hypertension when the average blood pressure was at least
140 mmHg systolic and/or 90 mmHg diastolic or if he/she reported having taken
antihypertensive drugs during the preceding 7 days.(Hu et al., 2005a) Awareness of
hypertension was defined as a participant having reported a previous diagnosis of
hypertension or current use of antihypertensive drug treatment. People on antihypertensive
drug treatment, whose measured blood pressure level was < 140/90 mmHg, were considered
to be adequately treated (controlled). The study population was classified into five groups
according to their blood pressure status at baseline: normotensive participants, unaware and
untreated hypertensive patients, hypertensive people aware of their hypertensive status but
untreated, patients treated with antihypertensive drugs and adequately treated, patients
treated with antihypertensive drugs but not controlled. After blood pressure measurement, a
venous blood specimen was taken. Total cholesterol was determined by an enzymatic method
(CHOD-PAP, Boehringer MANNHEIM, Mannheim, Germany). All samples were analyzed
in the same central laboratory at the National Public Health Institute.
In our previous publication, healthy lifestyle factors are defined as moderate or high level
of physical activity, never smoking, BMI <25 kg/m2, and vegetable consumption ≥3
times/week.(Wang et al., 2011a) Since we found a graded inverse association between the
number of healthy lifestyle factors and the risk of HF,(Wang et al., 2011a) a healthy lifestyle
was defined as having two or more healthy lifestyle factors.
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Prospective follow-up
Follow-up information was from the Finnish Hospital Discharge Register and the
National Social Insurance Institution’s Register on special reimbursement for HF drugs for
non-fatal outcomes and the Finnish Causes of Death Register for fatal outcomes by record
linkage using the personal identification numbers assigned to every citizen of Finland. The
International Classification of Diseases (ICD) codes 427.00 and 427.10 (ICD-8), 428, 4029B
(hypertensive heart disease with HF) and 4148A-X (ischemic HF with chronic coronary heart
disease) (ICD-9), and I 50, I11.0 (hypertensive heart disease with HF), I13.0 and I13.2
(hypertensive heart and renal disease with HF) (ICD-10) were used to identify HF cases in the
above-mentioned national databases. A HF diagnosis was made by the treating physicians,
based on a clinical assessment and examinations as considered relevant by the clinician in
charge of treatment. Follow-up of each cohort member continued until the date of the
diagnosis of HF from the Hospital Discharge Register, Causes of death register or from the
National Social Insurance Institution’s Drug reimbursement Register or death resulting from
causes other than HF, or December 31, 2007. The overall positive predictive value of HF
diagnosis in this FINRISK study was 85.9% (negative predictive value 97.9%).(Mahonen et
al., 2012)
Statistical analyses
Differences in the general characteristics of study subjects by blood pressure and lifestyle
status were tested using General Linear Models after adjustment for age, sex and study year.
Cox proportional hazards regression was used to calculate the hazard ratio (HR) and 95%
confidence intervals (CIs) for the five different blood pressure groups and the two different
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lifestyle groups. Next, participants were placed into 10 groups according to their blood
pressure and lifestyle status at baseline.

Cox proportional hazards regression was used to

estimate the association between the ten groups and HF risk. Different blood pressure and
lifestyle categories were included in the Cox proportional hazards regression models as
dummy and categorical variables, and the significance of the trend over different categories
was tested in the same models by giving an ordinal numeric value for each dummy variable.
The proportional hazards assumption in the Cox model was assessed with graphical methods,
and with models including time-by-covariate interactions.(Cox, 1972) In general, all
proportionality assumptions were appropriate.
All the above analyses were first carried out adjusting for age, sex, study year, and further
for education and alcohol consumption, and further for total cholesterol, and histories of
myocardial infarction, valvular heart disease, and diabetes. To avoid a potential bias due to
severe disease at baseline, additional analyses were carried out excluding the subjects who
died during the first two years of follow-up (n=290). In order to determine if the definition of a
healthy lifestyle used would influence the results, we did a sensitivity analysis whereby having
three or four healthy lifestyle factors constituted a healthy lifestyle. Men and women were
combined in the analyses because there was no significant gender difference. Statistical
significance was considered to be P<0.05. All the above statistical analyses were performed
with PASW for Windows, version 19.0 (SPSS Inc, Chicago, III).
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5.3 Results
During a median follow-up of 14.1 years (interquartile range 5.9-20.9 years), 638 men
and 445 women developed HF. General characteristics of the study population at baseline are
presented by blood pressure and lifestyle status in Table 13.
After adjustment for age, sex, study year, education and alcohol consumption
(multivariable model 2), the risk of HF was significantly higher in subjects in all
hypertensive groups compared with normotensive group, while the risk of HF was
significantly lower in the group with a healthy lifestyle compared with the group without a
healthy lifestyle (Table 14). Compared with the HF risk in the normotensive group, the risk
of HF increased 39% for the hypertensive, unaware, and untreated group, 51% for the
hypertensive, aware, and untreated group, 60% for the hypertensive, treated, and
uncontrolled group, 71% for the hypertensive, treated, and controlled one. The risk of HF
increased 84% among the group without a healthy lifestyle compared with the group with a
healthy lifestyle. Further adjustment for total cholesterol, and histories of myocardial
infarction, valvular heart disease, and diabetes affected these results only slightly.
Table 15 presents the HR of HF for subjects by different combinations of blood pressure
and lifestyle status. The multivariable-adjusted (model 2) HRs of HF in the ten subgroups (1]
normotensive group with a healthy lifestyle – reference group; 2] hypertensive, unaware,
untreated group with a healthy lifestyle; 3] hypertensive, aware, untreated group with a
healthy lifestyle; 4] hypertensive, treated, controlled group with a healthy lifestyle; 5]
hypertensive, treated, uncontrolled group with a healthy lifestyle; 6] normotensive group
without a healthy lifestyle; 7] hypertensive, unaware, untreated group without a healthy
lifestyle; 8] hypertensive, aware, untreated group without a healthy lifestyle; 9] hypertensive,
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Table 13. General characteristics of study subjects at baseline*
Healthy lifestyle factors ≥ 2

Healthy lifestyle factors < 2

Normoten

Hypertensive

Hypertensive

Hypertensive

Hypertensive

sive

unaware and

aware but

treated and

treated and

untreated

untreated

controlled

uncontrolled

14,859

5,797

3,815

553

2,238

Age at baseline (yrs)

41.1

49.1

48.9

54.0

Body mass index (kg/m2)

24.8

26.0

27.0

Diastolic blood pressure (mmHg)

76

86

Systolic blood pressure (mmHg)

124

Serum cholesterol (mmol/l)

P value

Normoten

Hypertensive

Hypertensive

Hypertensive

Hypertensive

sive

unaware and

Aware but

treated and

treated and

untreated

untreated

control

uncontrolled

4,359

3,075

1,853

269

1,257

56.3

42.9

51.2

50.3

55.4

57.7

<0.001

27.9

28.4

27.3

28.2

29.4

30.2

30.2

<0.001

92

80

91

76

87

93

78

92

<0.001

149

155

126

156

126

150

156

126

156

<0.001

5.59

5.89

5.89

5.62

5.77

5.83

6.05

6.08

5.75

5.87

<0.001

Education (yrs)

11.4

10.8

10.9

10.9

10.7

10.0

9.8

9.9

9.8

9.9

<0.001

Alcohol consumption (g/week)

43.6

50.0

53.2

45.6

49.8

55.4

68.9

75.2

53.0

61.7

<0.001

Low physical activity (%)

5.5

4.9

4.7

8.0

8.7

16.1

18.0

15.8

29.0

24.5

<0.001

No. of subjects
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Table 13 continued
Vegetable consumption ≥ 3 times/wk (%)

74.7

73.1

76.3

83.2

80.7

19.2

15.5

16.6

16.9

11.2

<0.001

Ever or current smoker (%)

39.1

37.0

37.5

41.7

37.4

74.1

67.8

64.7

65.5

59.6

<0.001

History of diabetes (%)

1.8

1.2

2.1

7.6

7.0

2.3

1.7

2.1

10.4

8.1

<0.001

History of myocardial infarction (%)

2.2

1.0

1.2

5.3

4.6

3.0

2.3

2.7

15.7

6.6

<0.001

History of valvular heart disease (%)

0.1

0.1

0.2

0.6

0.3

0.2

0.1

0.0

0.6

0.2

0.028

*Values represent mean or percentage; adjusted for age, sex and study year. Healthy lifestyle factors are defined as moderate or high level of
physical activity, never smoking, body mass index < 25 kg/m2, and vegetable consumption ≥ 3 times/week. Normotensive was defined as systolic
blood pressure < 140 mmHg, diastolic blood pressure < 90 mmHg and without antihypertensive drug treatment.
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Table 14. Hazard ratios of heart failure by lifestyle factors and hypertensive status*
No. of subjects

Case

Person-yrs

Model 1

Model 2

Model 3

HR (95% CI) †

HR (95% CI) ‡

HR (95% CI) §

Lifestyle factors
Healthy lifestyle factors ≥ 2

27,262

527

401,561

1.00

1.00

1.00

Healthy lifestyle factors < 2

10,813

556

152,284

1.88 (1.67-2.13)

1.84 (1.63-2.08)

1.79 (1.58-2.02)

<0.001

<0.001

<0.001

P trend
Hypertensive status
Normotensive

19,218

248

26,449

1.00

1.00

1.00

Hypertensive, unaware, untreated

8,872

397

125,835

1.39 (1.19-1.64)

1.39 (1.18-1.63)

1.40 (1.19-1.65)

Hypertensive, aware, untreated

5,668

208

198,441

1.52 (1.26-1.83)

1.51 (1.25-1.82)

1.49 (1.24-1.80)

822

31

152,777

1.63 (1.12-2.37)

1.60 (1.10-2.33)

1.34 (0.92-1.95)

3,495

199

50,343

1.72 (1.42-2.09)

1.71 (1.41-2.07)

1.53 (1.26-1.86)

<0.001

<0.001

<0.001

Hypertensive, treated, controlled
Hypertensive, treated, uncontrolled
P trend

*Normotensive was defined as systolic blood pressure < 140 mmHg, diastolic blood pressure < 90 mmHg and without antihypertensive drug
treatment.
†Adjusted for age, study year and sex.
‡Adjusted for age, study year, sex, education, alcohol consumption and lifestyle factors/hypertensive status.
§Adjusted for age, study year, sex, education, alcohol consumption, lifestyle factors/hypertensive status, total cholesterol, history of myocardial
infarction, history of valvular heart disease and history of diabetes.
CI = confidence interval; HR = hazard ratio.
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Table 15. Hazard ratios of heart failure in normotensive individuals* and in different categories of hypertensive individuals by different levels of
lifestyle factors
Model 1

Model 2

Model 3

HR (95% CI) ‡

HR (95% CI) §

1.00

1.00

1.00

91,520

1.52 (1.21-1.90)

1.50 (1.20-1.88)

1.51 (1.21-1.89)

93

55,258

1.56 (1.19-2.03)

1.54 (1.18-2.01)

1.51 (1.16-1.97)

553

19

6,300

2.28 (1.41-3.70)

2.24 (1.39-3.64)

1.96 (1.21-3.18)

2,238

94

28,259

1.93 (1.48-2.53)

1.91 (1.46-2.50)

1.69 (1.29-2.22)

Normotensive

4,359

113

61,093

2.18 (1.69-2.80)

2.12 (1.65-2.72)

2.03 (1.58-2.61)

Hypertensive, unaware, untreated

3,075

211

46,263

2.76 (2.21-3.45)

2.68 (2.14-3.35)

2.62 (2.09-3.28)

Hypertensive, aware, untreated

1,853

115

26,458

3.15 (2.45-4.05)

3.05 (2.37-3.93)

2.93 (2.27-3.77)

269

12

3,005

2.37 (1.31-4.29)

2.27 (1.25-4.11)

1.76 (0.97-3.19)

1,257

105

15,465

3.32 (2.55-4.31)

3.21 (2.47-4.18)

2.80 (2.14-3.65)

<0.001

<0.001

<0.001

No. of subjects

Case

Person-yrs

Normotensive

14,859

135

220,224

Hypertensive, unaware, untreated

5,797

186

Hypertensive, aware, untreated

3,815

HR (95% CI)

†

Healthy lifestyle factors ≥ 2

Hypertensive, treated, controlled
Hypertensive, treated, uncontrolled
Healthy lifestyle factors < 2

Hypertensive, treated, controlled
Hypertensive, treated, uncontrolled
P trend

*Normotensive was defined as systolic blood pressure < 140 mmHg, diastolic blood pressure < 90 mmHg and without antihypertensive drug treatment.
†Adjusted for age, study year and sex.
‡Adjusted for age, study year, sex, education, and alcohol consumption.
§Adjusted for age, study year, sex, education, alcohol consumption, total cholesterol, history of myocardial infarction, history of valvular heart disease
and history of diabetes.
CI = confidence interval; HR = hazard ratio.
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Table 16. Hazard ratios of heart failure by different lifestyle factors and hypertensive* subgroups
No. of
Case

Person-yrs

subjects

Model 1

Model 2

Model 3

HR (95% CI) †

HR (95% CI) ‡

HR (95% CI) §

Healthy lifestyle VS Medication
Hypertensive, untreated, healthy lifestyle factors ≥ 2

9,612

279

146,777

1.00

1.00

1.00

Hypertensive, treated, healthy lifestyle factors < 2†

1,526

117

18,469

2.17 (1.73-2.70)

2.10 (1.68-2.63)

1.75 (1.39-2.21)

Hypertensive, treated, healthy lifestyle factors ≥ 2

2,791

113

34,559

1.00

1.00

1.00

Hypertensive, untreated, healthy lifestyle factors < 2†

4,928

326

72,721

1.46 (1.17-1.82)

1.44 (1.16-1.80)

1.55 (1.24-1.95)

Healthy lifestyle + medication VS Non-healthy lifestyle + No medication

*Normotensive was defined as systolic blood pressure < 140 mmHg, diastolic blood pressure < 90 mmHg and without antihypertensive drug
treatment.
†Adjusted for age, study year and sex.
‡Adjusted for age, study year, sex, education, and alcohol consumption.
§Adjusted for age, study year, sex, education, alcohol consumption, total cholesterol, history of myocardial infarction, history of valvular heart
disease and history of diabetes.
CI = confidence interval; HR = hazard ratio.
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treated, controlled group without a healthy lifestyle; and 10] hypertensive, treated,
uncontrolled group without a healthy lifestyle) were 1.00, 1.50 (95% CI 1.20-1.88),
1.54(95% CI 1.18-2.01), 2.24 (95% CI 1.39-3.64), 1.91(95% CI 1.46-2.50), 2.12 (95% CI
1.65-2.72), 2.68 (95% CI 2.14-3.35), 3.05 (95% CI 2.37-3.93), 2.27 (95% CI 1.25-4.11), and
3.21 (95% CI 2.47-4.18) (Ptrend <0.001), respectively. Further adjustment for total cholesterol,
and histories of myocardial infarction, valvular heart disease, and diabetes did not
appreciably alter the results.
Table 16 presents the comparison between the association of engaging in a healthy
lifestyle with the risk of HF and the association of using antihypertensive drugs with the risk
of HF. In the multivariable-adjusted analyses (model 2), hypertensive subjects who used
antihypertensive drugs but did not engage in a healthy lifestyle had a significantly higher risk
of HF (HR 2.10; 95% CI 1.68-2.63) than hypertensive subjects who did not use
antihypertensive drug but engaged in a healthy lifestyle. Hypertensive subjects who did not
use antihypertensive drugs and did not engage in a healthy lifestyle had a significant higher
risk of HF (HR 1.44; 95% CI 1.16-1.80) compared with hypertensive subjects who used
antihypertensive drug and engaged in a healthy lifestyle. Further adjustment for total
cholesterol, and histories of myocardial infarction, valvular heart disease, and diabetes
affected these results only slightly.
5.4 Discussion
The results of the present study suggest that the risk of HF was higher in untreated
unaware, aware treated and controlled, and aware treated and uncontrolled hypertensive
people than in normotensive people. Treated hypertensive subjects without a healthy lifestyle
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had a higher risk of incident HF than untreated hypertensive subjects with a healthy lifestyle;
however, treated hypertensive subjects with a healthy lifestyle had a lower risk of incident
HF than untreated hypertensive subjects without a healthy lifestyle.
High blood pressure has long been shown as an independent risk factor for HF risk.
Levy et al.(Levy et al., 1996) showed that hypertensive subjects had an increased risk of HF.
In 2003, Haider et al.(Haider et al., 2003) demonstrated that elevated blood pressure was an
independent risk factor for incident HF. In addition to the evidence provided by
observational studies, numerous clinical trials have shown that blood pressure reduction
achieved with pharmacotherapy is associated with a decreased risk of HF in hypertensive
subjects.(Dahlof et al., 2005; Julius et al., 2004; Liu et al., 2005; Wing et al., 2003) The
current study supports the findings of the previous studies and adds additional information:
despite antihypertensive drug treatment and adequate control of hypertension, the risk of HF
remained relatively high. This stresses the importance of adequate primary prevention and
more effective early management of hypertension.
Modifiable lifestyle factors like smoking,(Djousse et al., 2009; Eriksson et al., 1989b; He
et al., 2001; Hoffman et al., 1994; Wilhelmsen et al., 2001) physical activity,(Djousse et al.,
2009; Hu et al., 2010b; Kenchaiah et al., 2009; Wang et al., 2010b) adiposity,(Djousse et al.,
2009; Hu et al., 2010b; Kenchaiah et al., 2002; Kenchaiah et al., 2009; Levitan et al.,
2009a) ,and dietary intake,(Djousse et al., 2009; Wang et al., 2011b) have been shown to be
independently associated with the risk of HF in various studies. Also, we found that there was
a graded inverse association between the number of healthy lifestyle factors and the risk of HF
in this Finnish population.(Wang et al., 2011a) In the current study, we assessed the joint
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effects of hypertensive status (awareness, antihypertensive drug treatment, blood pressure
control status) and lifestyle pattern on the risk of HF. We found that subjects engaged in a
healthy lifestyle at baseline generally had lower risk of HF than those did not, and this
association could be found in normotensive subjects as well as hypertensive subjects
regardless of their awareness, and treatment.
Numerous trials have investigated the effect of antihypertensive drug treatment on HF
risk in hypertensive subjects.(Dahlof et al., 2005; Julius et al., 2004; Liu et al., 2005; Wing et
al., 2003) However, no previous study had studied the differences in HF risk among
hypertensive people by antihypertensive treatment and lifestyle status. In the current study,
we first showed that the risk of incident HF was higher in the treated hypertensive subjects
without a healthy lifestyle than in the untreated hypertensive subjects with a healthy lifestyle.
Since one may argue that patients with treated hypertension might be more likely to have
severe hypertension than hypertensive patients with a healthy lifestyle, it cannot be
concluded that a healthy lifestyle may be more effective in preventing HF than
antihypertensive treatment in hypertensive subjects. In order to understand this possible bias,
we did additional analyses to compare the incident HF risk between the treated hypertensive
subjects who engaged in a healthy lifestyle and the untreated hypertensive subjects who did
not engage in a healthy lifestyle, and still found that a healthy lifestyle may be associated
with a further reduced HF risk in hypertensive people. Our finding supports the statement of
one recent review: “use a combination of lifestyle changes and pharmacotherapy to achieve
systolic blood pressure goals and to achieve the ultimate goal of reducing end-organ
damage”.(Baliga, 2007)

In 2010, the AHA published the AHA 2020 impact goals: “By
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2020, to improve the cardiovascular health of all Americans by 20% while reducing deaths
from cardiovascular diseases and stroke by 20%”.(Lloyd-Jones et al., 2010) In order to
achieve this goal, a new concept–cardiovascular health was introduced by the
AHA.(Lloyd-Jones et al., 2010) Seven metrics including not only health factor but also
health behaviours were proposed to be monitored to determine the changing prevalence of
cardiovascular health status.(Lloyd-Jones et al., 2010) Our results support the fundamental
expansion of prevention efforts proposed by the AHA.
There are several strengths and limitations in our study. First, a major strength of the study
is the large number of both men and women from a homogeneous population who participated
in the study. Second, the follow-up time was sufficiently long to ascertain a large number of
HF endpoint events. Finally, we also carried out additional analyses excluding the subjects
who died during the first two years of follow-up to avoid a potential bias due to a severe
disease at baseline. A limitation of our study is that information on self-reported physical
activity, smoking habits, vegetable consumption, alcohol consumption and antihypertensive
drug treatment was recorded only once at baseline. We have no data on possible changes in
these factors during the follow-up. However, the misclassification of the levels of these factors
during the follow-up is most probably not systematically related to the outcome, but may
weaken the observed association. In addition, we cannot completely either exclude the effects
of residual confounding due to measurement error in the assessment of confounding factors, or
some unmeasured dietary factors.
In conclusion, the present study demonstrates that the risk of HF increased in hypertensive
people despite antihypertensive drug treatment and adequate control of hypertension, which
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emphasized the importance of adequate primary prevention efforts. In addition, our study also
indicated that lifestyle intervention may be at least as effective in preventing HF as
antihypertensive treatment in hypertensive subjects, which justifies the inclusion of ideal
health behavioral factors into the definition of cardiovascular health of the AHA.(Lloyd-Jones
et al., 2010) The results may also help encourage people at high HF risk to engage in health
lifestyle changes while initiating medical therapy aiming at good blood pressure control.
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CHAPTER 6. CONCLUSIONS
It is generally believed that lifestyle interventions are beneficial in preventing and
treating cardiovascular diseases. However, scientific evidence is lacking regarding the effect
of engaging in healthy lifestyle in preventing heart failure (HF). In this dissertation: it is
demonstrated that 1) moderate and high levels of occupational or leisure-time physical
activity are associated with a reduced risk of HF; 2) coffee consumption is not detrimental to
HF patients; 3) maintaining a BMI ≤25 kg/m2, consuming vegetable ≥3 times a week,
abstaining from smoking and engaging in moderate or high level of physical activity were
individually and jointly associated with a decreased risk of HF among both men and women;
and 4) lifestyle intervention may be at least as effective in preventing HF as antihypertensive
treatment in hypertensive subjects. These results justified the recommendations, such as
increasing physical activity, eating healthy diet, stopping smoking and maintaining optimal
body weight, made by health-care professionals to the general public. Also, the result of our
studies may help to encourage people of high heart failure risk to attend lifestyle intervention
programs targeting reducing heart failure risk factors or preventing heart failure, and to
motivate health-care professionals to increase uptake to these programs.
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